This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
ILD, hospital admissions 3, with pneumonia sepsis
ILD_HOSPITAL_PNEUMONIA_SEPSIS
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
81046 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
3137 |
6. Filter based on genotype QC (FinnGen only) |
3137 |
Control definitions (FinnGen only)
- Control conditions
- not PULM_PNEUMONIA_SEPSIS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
ILD, hospital admissions 3, with pneumonia sepsis
based on the number of shared cases.
Similar with more cases:
- ILD, hospital admission 2, with pulmonary infections
- ILD, hospital admissions
- Interstitial lung disease
- Other interstitial pulmonary diseases
- Interstitial lung disease endpoints
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3137 | 1234 | 1903 |
| Unadjusted period prevalence (%) | 0.67 | 0.42 | 0.84 |
| Median age at first event (years) | 69.71 | 67.03 | 71.45 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2755
- Matched controls
- 27548
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J01MA14
ATC
moxifloxacin; systemic
12.3
323.0
687
726
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
168.0
323.0
1450
181
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
133.6
323.0
1340
194
H02AB06
ATC
prednisolone; systemic
10.6
323.0
2279
8570
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.1
323.0
1920
8602
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
28.7
323.0
953
498
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
10.7
323.0
1036
1467
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
185.2
323.0
883
70
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
190.5
323.0
918
72
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
24.0
323.0
532
272
J18.9
ICD-10 Finland
Pneumonia, unspecified
270.3
323.0
2414
700
TGC00
NOMESCO Finland
Bronchial lavation
45.5
323.0
670
193
UGC12
NOMESCO Finland
Flexible bronchoscopy
18.3
323.0
1108
975
R06.0
ICD-10 Finland
Dyspnoea
4.3
246.3
1221
4287
J96.1
ICD-10 Finland
Chronic respiratory failure
24.0
228.2
332
156
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
8.0
227.8
565
861
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
226.1
1422
6036
R03AC02
ATC
salbutamol; inhalant
3.5
205.8
1697
8702
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.7
205.3
666
1447
XG410
NOMESCO Finland
Flow-volume spirometry
10.6
199.8
411
449
GD1AD
NOMESCO Finland
Thorax CT examination
10.9
197.4
399
421
C03CA01
ATC
furosemide; systemic
3.4
196.3
1416
6465
L04AX01
ATC
azathioprine; systemic
11.8
191.7
371
358
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
8.0
188.9
464
683
R03BB04
ATC
tiotropium bromide; inhalant
5.5
188.6
627
1388
J01MA12
ATC
levofloxacin; systemic
4.1
186.8
889
2849
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.0
186.1
456
668
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.4
185.1
793
2298
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
14.1
177.6
315
250
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.2
173.8
781
2349
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.5
165.9
423
652
284
Kela drug reimbursment
Nintedanib and pirfenidone
62.7
165.3
193
33
A02BC02
ATC
pantoprazole; systemic
3.0
145.6
2033
13367
R50.9
ICD-10 Finland
Fever, unspecified
4.3
143.0
602
1664
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
10.5
142.8
291
305
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.9
137.2
496
1170
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.4
137.2
565
1523
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
43.1
136.1
170
42
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.7
133.7
1441
7886
356
Kela drug reimbursment
Nintedanib and pirfenidone
65.1
132.7
154
25
L04AA06
ATC
mycophenolic acid; systemic
21.3
129.8
195
98
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
9.2
129.1
283
337
L04AX05
ATC
pirfenidone; oral
82.0
124.6
140
18
I50.9
ICD-10 Finland
Heart failure, unspecified
3.4
124.5
729
2634
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
121.6
521
1443
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.8
118.7
590
1862
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
82.2
118.4
133
17
J01FA06
ATC
roxithromycin; oral
2.6
114.0
1261
6786
M05BA04
ATC
alendronic acid; oral
4.3
113.7
477
1289
R81
ICPC
Pneumonia
11.8
110.1
210
191
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
5.7
105.5
325
628
J45.9
ICD-10 Finland
Asthma, unspecified
3.2
105.1
644
2367
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
102.9
786
3349
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
97.2
101.8
112
12
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.0
99.0
219
262
J47
ICD-10 Finland
Bronchiectasis
13.6
98.2
175
137
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
+∞
97.5
93
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.2
96.6
326
698
P01BA02
ATC
hydroxychloroquine; oral
4.4
95.3
384
988
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
94.3
90
*
R02
ICPC
Shortness of breath/dyspnoea
3.5
94.0
509
1688
J01AA02
ATC
doxycycline; systemic
2.5
92.1
2187
16615
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
90.7
666
2735
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.9
90.6
680
2830
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
24.5
90.1
129
55
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
6.3
87.2
247
426
J01CA04
ATC
amoxicillin; systemic
2.4
86.8
2109
15885
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
108.1
86.5
94
9
H02AB07
ATC
prednisone; oral
3.1
85.9
553
2071
Z94.2
ICD-10 Finland
Lung transplant status
430.3
84.5
84
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.9
80.9
287
644
GDG10
NOMESCO Finland
Bilateral transplantation of lung
398.3
78.2
78
*
I50.0
ICD-10 Finland
Congestive heart failure
3.6
78.1
400
1257
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
76.6
706
3272
XG466
NOMESCO Finland
Sleep oxymetry
6.7
75.0
201
321
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.5
74.6
287
698
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
73.6
589
2507
J45.1
ICD-10 Finland
Nonallergic asthma
4.4
73.6
289
717
R4110
NOMESCO Finland
Physiotherapy
2.3
73.5
853
4440
WX892
NOMESCO Finland
Monitored bed care
3.8
73.4
339
975
R05
ICD-10 Finland
Cough
2.6
73.0
652
2956
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
72.8
481
1814
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.7
72.6
353
1060
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.2
70.1
923
5080
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
350.6
68.9
69
*
L01XE31
ATC
[U] nintedanib; oral
49.6
67.8
82
17
Z3226
NOMESCO Finland
Physiotherapist
2.5
65.8
613
2825
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
76.1
65.4
74
10
L04AD01
ATC
ciclosporin; systemic
12.0
65.2
122
106
A07EC01
ATC
sulfasalazine; oral, rectal
3.6
64.5
319
967
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
63.7
940
5388
N02AX02
ATC
tramadol; systemic, rectal
2.0
63.0
1266
8226
ZX120
NOMESCO Finland
Intravenous
3.2
61.8
355
1204
J12.8
ICD-10 Finland
Other viral pneumonia
+∞
61.7
59
*
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
12.7
60.9
111
91
127
Kela drug reimbursment
Transplant complication
13.5
60.5
107
82
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
110.9
60.1
65
6
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
59.4
766
4112
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
6.7
59.2
157
246
J43.9
ICD-10 Finland
Emphysema, unspecified
8.8
58.6
129
152
A02BC01
ATC
omeprazole; systemic
2.1
57.9
902
5243
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.6
57.7
214
499
A07AA02
ATC
nystatin; oral
3.7
57.4
272
793
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
56.5
599
2923
R04.2
ICD-10 Finland
Haemoptysis
5.1
56.5
189
395
C07AB07
ATC
bisoprolol; oral
1.9
56.1
1526
10912
R03AK07
ATC
formoterol and budesonide; inhalant
2.5
56.0
513
2318
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
558.8
55.8
55
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
55.6
393
1529
A03
ICPC
Fever
2.8
54.7
387
1503
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.4
54.2
281
880
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.6
53.2
263
793
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.7
53.2
252
734
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.7
52.9
159
293
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
52.5
644
3350
J15.8
ICD-10 Finland
Other bacterial pneumonia
62.3
52.5
61
10
N02AA05
ATC
oxycodone; systemic
2.4
52.3
537
2567
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
5.9
52.0
151
267
ZXE00
NOMESCO Finland
One hour or less
1.9
51.7
1098
7111
R28
ICPC
Limited function/disability (R)
10.7
51.6
102
99
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.8
51.6
180
393
L04AA13
ATC
leflunomide; oral
6.6
50.8
136
216
J01FF01
ATC
clindamycin; systemic
2.1
50.7
762
4317
J96.0
ICD-10 Finland
Acute respiratory failure
12.1
50.3
93
79
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
17.1
50.0
80
48
JN4BD
NOMESCO Finland
Extensive body CT
2.6
49.9
410
1737
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
49.3
789
4575
WW200
NOMESCO Finland
Immunization
6.0
48.1
138
240
J01DB01
ATC
cefalexin; oral
1.9
48.0
2074
16926
Z2221
NOMESCO Finland
Medical doctor
2.0
48.0
784
4575
B01AA03
ATC
warfarin; systemic
2.0
47.3
801
4732
ZX108
NOMESCO Finland
Inhalation
24.5
47.2
67
28
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
5.3
46.5
149
296
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
32.8
46.5
61
19
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
45.8
233
717
R03BA08
ATC
ciclesonide; inhalant
3.2
44.7
253
842
R03BA05
ATC
fluticasone; inhalant
2.3
44.4
493
2427
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
444.5
44.3
44
*
Z3231
NOMESCO Finland
Registered nurse
1.9
44.2
821
4999
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
43.7
1177
8119
Z2446
NOMESCO Finland
Social worker
3.5
43.6
215
645
48609
ICD-8 Finland
Pneumonia, unspecified
+∞
42.8
41
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
5.8
42.7
125
223
R03BA02
ATC
budesonide; inhalant
2.2
42.2
478
2368
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
42.2
441
2105
WX725
NOMESCO Finland
Noninvasive ventilation
4.0
41.9
174
451
R03BA01
ATC
beclometasone; inhalant
2.4
41.8
406
1870
R05
ICPC
Cough
2.1
41.7
590
3221
R03AK08
ATC
formoterol and beclometasone; inhalant
4.7
41.5
147
326
A28
ICPC
Limited function/disability NOS
2.1
41.2
548
2914
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
10.5
41.0
81
79
R03DA04
ATC
theophylline; systemic, rectal
3.3
40.7
221
713
ZXD05
NOMESCO Finland
Urgent procedure
1.8
40.2
840
5294
N02BE01
ATC
paracetamol; systemic, rectal
1.9
39.9
2254
19334
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
33.1
39.8
52
16
R03DC03
ATC
montelukast; oral
2.4
39.7
390
1802
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
39.6
156
385
A02BC05
ATC
esomeprazole; systemic
1.7
39.2
1073
7362
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.1
38.4
157
401
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
6.2
37.9
105
175
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.9
37.7
242
876
J01FA10
ATC
azithromycin; systemic
1.7
37.6
1258
9129
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
37.2
844
5437
WX872
NOMESCO Finland
Intensive care
3.3
37.1
195
613
M04AA01
ATC
allopurinol; systemic
2.1
37.1
490
2588
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
36.6
408
1997
XW000
NOMESCO Finland
Bone marrow biopsy
3.7
36.0
167
476
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.8
35.9
836
5417
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.3
35.2
110
213
R99
ICPC
Respiratory disease other
6.2
35.2
97
161
WX722
NOMESCO Finland
PEEP
3.4
35.1
180
556
48499
ICD-8 Finland
Acute interstitial pneumonia
67.5
35.0
40
6
Z51.5
ICD-10 Finland
Palliative care
2.8
34.7
244
934
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
10.5
34.6
68
66
H02AB04
ATC
methylprednisolone; systemic
2.2
34.1
407
2050
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
17.2
34.1
54
32
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
6.2
34.1
94
156
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.5
33.7
124
286
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
33.6
268
1103
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.1
33.6
424
2186
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.6
33.5
158
457
XX4BW
NOMESCO Finland
NA
41.5
33.1
41
10
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
33.1
984
6825
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
33.0
713
4483
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
12.8
33.0
59
47
R03AC12
ATC
salmeterol; inhalant
3.4
32.8
165
502
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.1
32.6
106
215
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
15.9
32.5
53
34
A01AB09
ATC
miconazole; local oral
2.4
32.2
285
1239
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
32.2
297
1323
J01FA15
ATC
telithromycin; oral
2.6
31.9
258
1072
N05CF01
ATC
zopiclone; oral
1.7
31.8
915
6266
JN4AD
NOMESCO Finland
Body CT examination
2.5
31.6
264
1113
A02BC03
ATC
lansoprazole; oral
1.7
31.6
823
5474
J45.8
ICD-10 Finland
Mixed asthma
4.5
31.6
115
263
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
+∞
31.3
30
*
GDA10
NOMESCO Finland
Biopsy of lung
28.4
31.1
42
15
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
12.4
31.0
56
46
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
12.4
31.0
56
46
J46
ICD-10 Finland
Status asthmaticus
5.3
30.9
96
185
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.5
30.9
94
177
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.4
30.8
156
477
XF600
NOMESCO Finland
Bloodpressure measurement
2.7
30.8
221
855
A46
ICD-10 Finland
Erysipelas
2.0
30.8
423
2255
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.5
30.7
250
1039
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
5.6
30.2
90
165
N03AX16
ATC
pregabalin; oral
1.8
30.2
608
3722
WX726
NOMESCO Finland
High-flow oxygen therapy
59.0
30.1
35
6
WX882
NOMESCO Finland
High dependency care
4.4
30.0
111
258
R03BB01
ATC
ipratropium bromide; inhalant
3.1
29.9
170
565
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.7
29.9
223
884
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
29.5
314
1496
SPAT1255
SPAT
Intravenous administration of medicine
2.7
29.4
212
822
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
29.4
168
562
L04AA01
ATC
[U] ciclosporin; systemic
7.0
29.3
73
106
J80
ICD-10 Finland
Adult respiratory distress syndrome
24.4
29.2
41
17
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
57.3
29.1
34
6
R06AE07
ATC
cetirizine; oral
1.6
29.1
959
6776
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.5
29.1
247
1052
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.8
28.7
83
147
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.1
28.6
349
1768
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.5
28.5
234
978
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
28.5
502
2930
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
28.4
795
5364
J01FA09
ATC
clarithromycin; systemic
1.7
28.3
709
4635
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
64.7
27.9
32
5
M05BA07
ATC
risedronic acid; oral
3.5
27.9
137
409
L88
ICPC
Rheumatoid/seropositive arthritis
3.7
27.9
127
357
J20
ICD-10 Finland
Acute bronchitis
2.4
27.9
255
1126
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
27.8
320
1577
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
78.4
27.8
31
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.8
27.5
119
320
J01MA02
ATC
ciprofloxacin; systemic
1.6
27.4
1079
7951
J01DA01
ATC
[U] cefalexin; systemic
1.6
27.3
1554
12515
WX721
NOMESCO Finland
Oxygen concentrator therapy
30.4
27.2
36
12
J18
ICD-10 Finland
Pneumonia, organism unspecified
12.5
26.8
48
39
AA1AD
NOMESCO Finland
CT of head and brain
1.7
26.7
690
4537
L01EX09
ATC
nintedanib; oral
28.0
26.7
36
13
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
26.5
1008
7346
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
26.5
324
1639
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.3
26.5
100
238
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.4
26.4
235
1025
F1246
NOMESCO Finland
NA
26.0
26.2
36
14
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
26.2
926
6624
WZC30
NOMESCO Finland
Teaching
2.0
26.1
369
1980
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
26.1
297
1456
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.5
26.0
78
145
R06.2
ICD-10 Finland
Wheezing
3.4
25.9
132
406
J84
ICD-10 Finland
Other interstitial pulmonary diseases
136.2
25.6
27
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
25.6
173
646
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
25.5
385
2114
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
25.5
412
2325
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
25.5
343
1806
SPAT1263
SPAT
Sampling
1.6
25.4
1072
7989
C01DA14
ATC
isosorbide mononitrate; oral
1.7
25.4
606
3884
AN1
HP
Coronary angiography
1.9
25.2
431
2476
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
4.5
25.2
91
207
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.6
25.2
119
345
D07AC01
ATC
betamethasone; topical
1.6
25.1
864
6120
48509
ICD-8 Finland
Bronchopneumonia, unspecified
+∞
25.0
24
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.0
25.0
154
541
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
6.8
24.9
63
94
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
7.1
24.9
61
87
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
131.1
24.6
26
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.0
24.6
147
507
E0000UV
ATC
NA
1.6
24.6
922
6662
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
5.9
24.5
69
119
TK800
NOMESCO Finland
Hemodialysis
5.0
24.4
80
165
J86.9
ICD-10 Finland
Pyothorax without fistula
14.3
24.4
41
29
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.7
24.3
169
642
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.3
24.2
92
221
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
56.5
24.0
28
5
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.9
24.0
153
550
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.2
23.9
75
147
J43.8
ICD-10 Finland
Other emphysema
22.9
23.9
34
15
C03DA01
ATC
spironolactone; oral
2.0
23.8
344
1858
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.7
23.7
82
179
120
Kela drug reimbursment
Hypogammaglobulinaemia
241.9
23.7
24
*
J96.9
ICD-10 Finland
Respiratory failure, unspecified
12.2
23.2
42
35
B01AB05
ATC
enoxaparin; parenteral
1.6
23.2
811
5743
M10.9
ICD-10 Finland
Gout, unspecified
2.3
23.2
230
1057
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.2
23.0
89
217
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
22.9
417
2446
XG460
NOMESCO Finland
Short time oxymetry
4.5
22.9
82
186
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.4
22.7
83
192
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
231.7
22.6
23
*
2AX04
NOMESCO Finland
NA
121.0
22.6
24
*
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
13.2
22.4
39
30
R03AC03
ATC
terbutaline; inhalant
1.9
22.4
333
1818
I50.1
ICD-10 Finland
Left ventricular failure
2.6
22.3
173
698
R03AC13
ATC
formoterol; inhalant
2.8
22.2
145
530
M81.4
ICD-10 Finland
Drug-induced osteoporosis
16.9
22.2
35
21
M05BX04
ATC
denosumab; parenteral
2.6
22.2
166
658
SPAT1262
SPAT
Handing over of treatment supplies
1.7
22.1
531
3390
RS123
NOMESCO Finland
NA
63.0
21.9
25
*
J05AB11
ATC
valaciclovir; oral
1.9
21.8
325
1774
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.9
21.8
133
466
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
21.6
164
656
R95
ICPC
Chron obstructive pulmonary disease
3.7
21.6
95
261
S97
ICPC
Chronic ulcer skin
2.5
21.6
175
725
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
4.9
21.5
71
148
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
21.5
425
2557
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.4
21.4
183
779
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
21.3
208
948
D86.0
ICD-10 Finland
Sarcoidosis of lung
6.1
21.3
58
96
G47.3
ICD-10 Finland
Sleep apnoea
1.7
21.3
493
3110
E000001
ATC
NA
1.7
21.3
480
3007
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.4
21.2
77
177
F2680
NOMESCO Finland
NA
20.9
21.2
31
15
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
21.1
257
1291
J43.2
ICD-10 Finland
Centrilobular emphysema
15.6
21.0
34
22
R53
ICD-10 Finland
Malaise and fatigue
1.7
21.0
502
3196
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
4.7
20.9
72
157
SPAT1325
SPAT
Vaccination
1.5
20.9
991
7493
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
20.9
590
3936
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
+∞
20.9
20
*
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
10.7
20.8
40
38
L01AA01
ATC
cyclophosphamide; systemic
11.7
20.7
38
33
M01CB01
ATC
sodium aurothiomalate; parenteral
4.9
20.5
67
138
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
42.0
20.4
25
6
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
20.3
762
5453
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
20.2
115
384
C09AA05
ATC
ramipril; oral
1.5
20.2
762
5462
5AB14
NOMESCO Finland
NA
48.4
20.1
24
5
M13.9
ICD-10 Finland
Arthritis, unspecified
2.3
20.1
189
844
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
20.1
1041
7998
A06AD11
ATC
lactulose; oral
1.7
19.9
446
2784
J02AC01
ATC
fluconazole; systemic
1.5
19.9
752
5388
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.6
19.8
51
79
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
19.6
334
1909
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
19.5
743
5326
J02AC03
ATC
voriconazole; systemic
40.4
19.5
24
6
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
21.7
19.5
28
13
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
21.7
19.5
28
13
WW500
NOMESCO Finland
Blood transfusion
2.8
19.4
126
457
B02.9
ICD-10 Finland
Zoster without complication
2.3
19.3
181
808
I50
ICD-10 Finland
Heart failure
2.8
19.0
122
443
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
18.9
826
6097
SPAT1254
SPAT
Administration of medicine
1.8
18.9
389
2361
J94.1
ICD-10 Finland
Fibrothorax
34.5
18.9
24
7
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.9
18.8
116
410
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.2
18.7
200
953
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
7.4
18.7
44
60
R03AK11
ATC
formoterol and fluticasone; inhalant
4.0
18.5
75
192
R05FB02
ATC
cough suppressants and expectorants
1.5
18.3
956
7319
N06AX11
ATC
mirtazapine; oral
1.5
18.3
706
5062
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
18.3
418
2618
WX002
NOMESCO Finland
Sedation and analgesia
1.6
18.3
518
3443
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.6
18.1
39
46
L04AB04
ATC
adalimumab; parenteral
5.3
18.1
55
105
XX9XE
NOMESCO Finland
Other ultrasound examination
9.4
18.1
37
40
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.3
18.1
173
782
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
18.0
767
5620
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.5
17.9
668
4750
L28
ICPC
Limited function/disability (L)
1.7
17.9
447
2871
H02AB09
ATC
hydrocortisone; systemic
4.2
17.8
68
165
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
26.9
17.8
24
9
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
17.8
207
1022
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
20.2
17.7
26
13
3A006
NOMESCO Finland
NA
+∞
17.7
17
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.4
17.7
53
100
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
36.9
17.6
22
6
XG405
NOMESCO Finland
Education on PEF monitoring
5.1
17.6
55
109
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.1
17.5
214
1078
A04
ICPC
Weakness/tiredness general
1.8
17.5
334
1980
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.8
17.5
115
422
RK320
NOMESCO Finland
NA
5.9
17.4
48
82
ZXA10
NOMESCO Finland
Bilateral
1.6
17.2
513
3452
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
17.2
362
2209
N02AA01
ATC
morphine; systemic, rectal
4.1
17.1
66
162
UJF32
NOMESCO Finland
Coloscopy
1.5
17.1
681
4906
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.8
17.1
110
400
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
17.1
191
928
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
17.1
843
6359
M31.3
ICD-10 Finland
Wegener granulomatosis
16.0
17.0
27
17
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
16.9
496
3320
RK110
NOMESCO Finland
NA
6.6
16.9
43
66
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
10.1
16.9
33
33
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.9
16.8
69
180
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.9
16.8
70
185
J05AB01
ATC
aciclovir; systemic
1.6
16.7
475
3153
C01AA05
ATC
digoxin; systemic
1.8
16.7
297
1718
N18.8
ICD-10 Finland
Other chronic renal failure
2.9
16.5
101
355
J99.0
ICD-10 Finland
Rheumatoid lung disease
170.9
16.5
17
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
170.9
16.5
17
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
16.5
125
501
ZXA05
NOMESCO Finland
Left side
1.5
16.4
686
4989
M33.2
ICD-10 Finland
Polymyositis
20.2
16.4
24
12
XJC10
NOMESCO Finland
Oesophageal pH monitoring
9.5
16.4
33
35
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
16.3
146
639
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
16.3
652
4693
GX1K5
NOMESCO Finland
Diffusion capacity
14.3
16.3
27
19
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.3
16.3
82
253
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.2
16.3
175
833
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
16.2
171
809
GAA31
NOMESCO Finland
Thoracoscopy
8.8
16.2
34
39
5BA08
NOMESCO Finland
NA
9.3
16.1
33
36
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
16.1
157
717
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
16.1
757
5642
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.2
16.0
85
272
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
47.8
16.0
19
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
16.0
279
1604
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
16.0
263
1483
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.3
15.8
81
253
A02BA02
ATC
ranitidine; systemic
1.5
15.8
549
3825
A01AB04
ATC
amphotericin B; local oral
2.4
15.7
141
616
ZXA00
NOMESCO Finland
Right side
1.5
15.7
724
5368
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.0
15.7
91
310
D07AC13
ATC
mometasone; topical
1.5
15.7
678
4956
1240
FHL
Bronchoscopy
4.5
15.7
55
124
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
15.6
749
5595
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.0
15.6
208
1085
WX110
NOMESCO Finland
Local anesthesy
1.4
15.5
1489
12637
D07AB08
ATC
desonide; topical
1.9
15.4
252
1417
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.9
15.3
62
160
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
5.1
15.1
47
93
SPAT1060
SPAT
Administration of oxygen
14.0
15.0
25
18
WZA10
NOMESCO Finland
Long statement of health and health related matters
5.3
15.0
45
86
R4190
NOMESCO Finland
Nutritional therapy
3.2
14.9
79
253
J94.8
ICD-10 Finland
Other specified pleural conditions
3.8
14.9
62
164
J45
ICD-10 Finland
Asthma
2.0
14.8
204
1076
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.1
14.8
80
260
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
14.8
262
1513
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
14.8
229
1262
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.1
14.7
80
262
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
4.4
14.6
52
119
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.4
14.6
52
119
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.2
14.6
78
252
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
14.6
14
*
J92.9
ICD-10 Finland
Pleural plaque without asbestos
4.0
14.6
58
148
N05CD07
ATC
temazepam; oral
1.7
14.5
356
2265
N03AX12
ATC
gabapentin; oral
1.7
14.5
357
2275
J01GB01
ATC
tobramycin; inhalant, parenteral
150.7
14.5
15
*
207
Kela drug reimbursment
Chronic arrhythmias
1.6
14.4
463
3161
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
12.6
14.4
25
20
L04AB01
ATC
etanercept; parenteral
5.3
14.3
43
82
R74
ICPC
Upper respiratory infection acute
1.6
14.3
434
2920
R96
ICPC
Asthma
2.0
14.2
195
1029
RS230
NOMESCO Finland
NA
9.7
14.2
28
29
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
4.9
14.2
46
96
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
14.1
973
7754
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
14.0
136
621
J93.8
ICD-10 Finland
Other pneumothorax
8.9
13.9
29
33
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
12.7
13.9
24
19
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.2
13.9
139
642
I25.2
ICD-10 Finland
Old myocardial infarction
1.8
13.8
248
1436
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
7.8
13.8
31
40
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
17.6
13.8
21
12
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.7
13.8
289
1759
M05.1
ICD-10 Finland
Rheumatoid lung disease
53.6
13.8
16
*
J67.0
ICD-10 Finland
Farmer lung
53.6
13.8
16
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
13.7
668
4982
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
13.7
146
694
RK250
NOMESCO Finland
NA
10.5
13.7
26
25
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.7
13.7
91
340
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.2
13.6
140
654
R01AD08
ATC
fluticasone; nasal
1.5
13.6
557
4009
B59
ICD-10 Finland
Pneumocystosis
75.5
13.6
15
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
75.5
13.6
15
*
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
140.6
13.5
14
*
M34.1
ICD-10 Finland
CR(E)ST syndrome
10.1
13.4
26
26
B01AC04
ATC
clopidogrel; oral
1.5
13.4
483
3379
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.5
13.4
62
180
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.9
13.3
211
1174
L03AA02
ATC
filgrastim; parenteral
3.0
13.3
76
257
C10AA03
ATC
pravastatin; oral
1.8
13.2
229
1314
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.7
13.2
91
347
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
13.2
135
631
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
9.7
13.2
26
27
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.8
13.2
221
1254
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.3
13.1
118
517
WX730
NOMESCO Finland
Conventional respirator
3.9
13.0
53
139
TGD00
NOMESCO Finland
Needle biopsy of lung
8.8
13.0
27
31
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
12.9
736
5648
GX2C5
NOMESCO Finland
Short-lasting oximetry
19.1
12.9
19
10
GD1UN
NOMESCO Finland
Lung circulation SPECT
6.4
12.9
33
52
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
12.9
167
864
B01AF02
ATC
apixaban; oral
1.7
12.9
302
1896
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.0
12.8
164
843
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.0
12.8
73
245
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
6.6
12.8
32
49
RS220
NOMESCO Finland
NA
4.7
12.7
42
90
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
12.7
191
1044
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.8
12.7
80
290
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.2
12.7
65
205
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.5
12.6
58
168
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.9
12.6
40
82
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.3
12.6
46
109
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
15.5
12.6
20
13
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
70.2
12.6
14
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
70.2
12.6
14
*
5169X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy
70.2
12.6
14
*
M79.6
ICD-10 Finland
Pain in limb
1.4
12.6
783
6098
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
12.6
164
849
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
+∞
12.5
12
*
J42
ICD-10 Finland
Unspecified chronic bronchitis
4.6
12.5
42
92
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
12.4
645
4858
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
130.5
12.4
13
*
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
130.5
12.4
13
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.3
12.4
117
528
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
12.4
117
528
GD2SN
NOMESCO Finland
Lung ventilation SPECT
6.1
12.4
33
55
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.1
12.4
67
220
81
HP
Angiography of the heart and coronary arteries
1.8
12.3
231
1357
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
12.3
312
2005
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
4.5
12.2
42
94
M54.5
ICD-10 Finland
Low back pain
1.4
12.2
661
5018
R60.0
ICD-10 Finland
Localized oedema
1.7
12.1
286
1800
R11
ICD-10 Finland
Nausea and vomiting
1.9
12.1
173
929
L04AA24
ATC
abatacept; parenteral
12.4
12.1
21
17
3AC01
NOMESCO Finland
NA
5.4
12.1
35
65
ZY010
NOMESCO Finland
Hospital outpatient
2.6
12.1
85
330
E000003
ATC
NA
2.3
12.0
109
482
SPAT1260
SPAT
Consultation of another employee
1.5
12.0
424
2945
1CX01
NOMESCO Finland
NA
26.8
12.0
16
6
XX4AW
NOMESCO Finland
NA
26.8
12.0
16
6
GX1D5
NOMESCO Finland
Flow volume spirometry
21.4
12.0
17
8
Z57.2
ICD-10 Finland
Occupational exposure to dust
8.7
12.0
25
29
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.2
12.0
63
203
A02BA03
ATC
famotidine; systemic
2.2
11.9
128
610
J98.4
ICD-10 Finland
Other disorders of lung
13.4
11.9
20
15
1XC02
NOMESCO Finland
NA
5.7
11.9
33
58
B34.9
ICD-10 Finland
Viral infection, unspecified
3.4
11.9
56
166
N19
ICD-10 Finland
Unspecified kidney failure
2.3
11.9
113
511
R29
ICPC
Respiratory symptom/complaint other
2.0
11.8
142
713
TFP20
NOMESCO Finland
Cardiodefibrillation
1.8
11.8
218
1273
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
11.8
214
1245
UJD02
NOMESCO Finland
Gastroscopy
2.1
11.8
130
631
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
11.7
221
1300
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.4
11.7
96
405
RS221
NOMESCO Finland
NA
4.1
11.7
44
108
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
5.0
11.7
36
72
R04.0
ICD-10 Finland
Epistaxis
1.8
11.7
208
1203
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.6
11.6
51
143
J01FA01
ATC
erythromycin; systemic
1.7
11.6
247
1508
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
65.2
11.6
13
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
8.1
11.5
25
31
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
11.5
219
1291
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.3
11.5
105
464
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
11.5
11
*
AK3
HP
BLTX (both lung transplants)
+∞
11.5
11
*
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
+∞
11.5
11
*
304
Kela drug reimbursment
Dornase alfa
+∞
11.5
11
*
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
120.4
11.4
12
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.0
11.4
66
226
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.2
11.4
112
515
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
11.4
125
606
XQ800
NOMESCO Finland
Prick test
2.1
11.4
122
584
A01
ICPC
Pain general/multiple sites
1.9
11.3
174
960
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
11.3
252
1563
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.8
11.3
208
1217
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
6.6
11.2
28
43
R01AD09
ATC
mometasone; nasal
1.4
11.2
864
6949
M34.0
ICD-10 Finland
Progressive systemic sclerosis
25.1
11.1
15
6
R4120
NOMESCO Finland
Occupational therapy
2.0
11.1
142
731
R2110
NOMESCO Finland
Giving the first information
2.0
11.1
142
731
R24
ICPC
Haemoptysis
7.1
11.0
26
37
WX720
NOMESCO Finland
Own respiration
2.4
11.0
94
405
TGA30
NOMESCO Finland
Thoracocentesis
5.6
11.0
31
56
A10AE04
ATC
insulin glargine; parenteral
1.7
11.0
214
1271
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.8
11.0
197
1143
N05BA04
ATC
oxazepam; oral
1.4
11.0
533
3953
B01AB10
ATC
tinzaparin; parenteral
1.9
10.9
167
917
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
43.5
10.9
13
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
15.5
10.8
17
11
R13
ICD-10 Finland
Dysphagia
1.9
10.8
160
869
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.2
10.8
109
510
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.3
10.8
52
158
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
10.8
164
901
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.0
10.8
136
698
N06AA09
ATC
amitriptyline; systemic
1.7
10.8
234
1440
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
10.6
10.8
20
19
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
10.7
97
427
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
6.1
10.7
28
46
D07AA02
ATC
hydrocortisone; topical
1.6
10.7
271
1738
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
6.7
10.7
26
39
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.2
10.7
112
531
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.1
10.6
57
187
P01AB01
ATC
metronidazole; oral, rectal
1.3
10.6
819
6573
I26
ICD-10 Finland
Pulmonary embolism
5.0
10.6
33
67
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
8.0
10.6
23
29
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.9
10.6
42
109
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.9
10.6
62
216
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
11.2
10.5
19
17
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
6.5
10.5
26
40
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
14.2
10.5
17
12
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.8
10.5
67
247
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.0
10.4
60
205
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
10.4
10
*
J01XB01
ATC
colistin; inhalant, parenteral
+∞
10.4
10
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
5.9
10.4
28
48
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
10.4
578
4394
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
16.1
10.3
16
10
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
3.2
10.3
53
169
XF404
NOMESCO Finland
Ambulatory ECG
1.6
10.3
244
1535
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
10.3
394
2779
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
8.2
10.3
22
27
N17.8
ICD-10 Finland
Other acute renal failure
4.1
10.3
39
97
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
10.3
261
1674
S22.3
ICD-10 Finland
Fracture of rib
1.9
10.3
156
856
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
6.0
10.3
27
45
WNF00
NOMESCO Finland
Infection source and contact determination
8.8
10.3
21
24
B03XA02
ATC
darbepoetin alfa; parenteral
3.2
10.3
51
159
M33.1
ICD-10 Finland
Other dermatomyositis
18.8
10.2
15
8
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
23.4
10.2
14
6
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.7
10.2
66
245
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.8
10.2
64
232
GDC00
NOMESCO Finland
Lobectomy of lung
5.9
10.1
27
46
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
5.4
10.1
29
54
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.9
10.0
59
206
NHQ40
NOMESCO Finland
Amputation of toe
3.0
10.0
55
184
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
10.0
427
3083
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
8.5
10.0
21
25
N06AB04
ATC
citalopram; systemic
1.5
10.0
428
3091
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
10.0
548
4149
ZX121
NOMESCO Finland
Central venous catheter
10.1
10.0
19
19
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.6
10.0
72
285
R03AC18
ATC
indacaterol; inhalant
5.3
10.0
29
55
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
5.5
9.9
28
51
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.2
9.9
97
446
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
3.5
9.9
44
126
E000002
ATC
NA
1.7
9.9
224
1394
318
Kela drug reimbursment
Teriparatide
6.7
9.9
24
36
I27.0
ICD-10 Finland
Primary pulmonary hypertension
16.7
9.9
15
9
C08CA01
ATC
amlodipine; oral
1.3
9.8
958
7951
UGC02
NOMESCO Finland
Rigid bronchoscopy
10.6
9.8
18
17
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.2
9.7
96
445
J98.2
ICD-10 Finland
Interstitial emphysema
55.2
9.6
11
*
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
55.2
9.6
11
*
M01AH02
ATC
rofecoxib; oral
1.5
9.6
323
2215
XX7LW
NOMESCO Finland
NA
11.4
9.5
17
15
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
10.1
9.5
18
18
A11CC03
ATC
alfacalcidol; systemic
2.8
9.5
58
209
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.8
9.5
38
100
Z71.8
ICD-10 Finland
Other specified counselling
1.4
9.5
447
3288
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.0
9.4
52
175
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
9.4
176
1035
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
4.1
9.4
35
86
M05BA06
ATC
ibandronic acid; systemic
2.8
9.4
59
213
ZX100
NOMESCO Finland
Oral
3.0
9.4
51
170
291
Kela drug reimbursment
Tofacitinib
17.6
9.4
14
8
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
4.3
9.4
33
77
R01AD12
ATC
fluticasone furoate; nasal
1.4
9.4
486
3638
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.4
9.4
44
132
K77
ICPC
Heart failure
2.6
9.4
67
263
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
6.2
9.4
24
39
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.4
9.3
43
127
6BA02
NOMESCO Finland
NA
12.4
9.3
16
13
A02BA04
ATC
nizatidine; systemic
1.7
9.3
210
1304
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
9.3
178
1054
UDC00
NOMESCO Finland
Ear microscopy
1.7
9.3
178
1054
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.8
9.3
38
102
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
9.2
153
867
R03BB06
ATC
glycopyrronium bromide; inhalant
6.4
9.2
23
36
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
9.2
179
1066
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
5.5
9.2
26
48
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
13.7
9.2
15
11
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.1
9.2
95
451
J01DA06
ATC
[U] cefuroxime; systemic
1.5
9.1
297
2022
D70.89
ICD-10 Finland
Neutropenic splenomegaly
4.3
9.1
32
75
EB1WA
NOMESCO Finland
NA
6.3
9.1
23
37
GX2D5
NOMESCO Finland
Sleep oximetry
8.3
9.1
19
23
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
9.0
201
1245
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
9.0
9.0
18
20
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
36.8
9.0
11
*
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
36.8
9.0
11
*
L01BB05
ATC
fludarabine; systemic
36.8
9.0
11
*
ZX197
NOMESCO Finland
NA
36.8
9.0
11
*
D07XC01
ATC
betamethasone, combinations; topical
1.5
9.0
280
1885
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.8
8.9
143
801
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.2
8.9
91
429
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
8.9
370
2651
RD210
NOMESCO Finland
NA
3.5
8.9
40
116
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
2.6
8.9
64
251
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
24.1
8.9
12
5
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.7
8.9
37
101
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
8.9
193
1188
N05BA01
ATC
diazepam; systemic, rectal
1.5
8.9
289
1970
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
5.5
8.9
25
46
NDG30
NOMESCO Finland
Fusion of wrist, total
5.5
8.9
25
46
JN4CD
NOMESCO Finland
Very extensive body CT
2.0
8.9
106
533
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.7
8.9
57
212
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.0
8.8
113
585
A07AA09
ATC
vancomycin; oral
3.8
8.8
35
92
M25.5
ICD-10 Finland
Pain in joint
1.4
8.8
534
4106
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.4
8.8
40
118
ZY000
NOMESCO Finland
Hospital inpatient
5.1
8.8
26
51
R4130
NOMESCO Finland
Speech therapy
2.7
8.8
57
214
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
5.6
8.7
24
43
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
8.7
183
1118
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
8.7
115
601
B01AB04
ATC
dalteparin; parenteral
1.9
8.7
127
688
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
8.7
552
4278
N07BA03
ATC
varenicline; oral
2.3
8.7
79
355
H26.3
ICD-10 Finland
Drug-induced cataract
6.6
8.6
21
32
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.8
8.6
153
887
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
8.6
140
788
ZX114
NOMESCO Finland
Intramuscular
3.4
8.6
40
120
N06AX16
ATC
venlafaxine; oral
1.6
8.6
206
1303
RK120
NOMESCO Finland
NA
8.2
8.6
18
22
S18
ICPC
Laceration/cut
1.3
8.6
1007
8527
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
8.5
236
1547
R04
ICPC
Breathing problem other
2.4
8.5
71
303
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
8.5
570
4451
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
8.5
325
2294
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
4.3
8.5
30
71
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
27.6
8.5
11
*
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.7
8.4
160
947
Z94.3
ICD-10 Finland
Heart and lungs transplant status
90.3
8.4
9
*
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
90.3
8.4
9
*
L95
ICPC
Osteoporosis
2.3
8.4
76
337
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.3
8.4
76
338
D72.1
ICD-10 Finland
Eosinophilia
7.9
8.3
18
23
4829X
ICD-9 Finland
Other bacterial pneumonia, Bacterial pneumonia unspecified
+∞
8.3
8
*
48601
ICD-8 Finland
More specifically, unspecified pneumonia and the pleural irritation caused by it
+∞
8.3
8
*
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
3.9
8.3
32
82
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
5.0
8.3
25
50
K29.7
ICD-10 Finland
Gastritis, unspecified
2.1
8.3
89
430
H05AA02
ATC
teriparatide; parenteral
6.2
8.3
21
34
M70.2
ICD-10 Finland
Olecranon bursitis
2.2
8.3
84
396
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
4.4
8.2
28
64
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
8.2
449
3388
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
8.2
350
2526
WX740
NOMESCO Finland
Nitrogen oxide therapy
14.5
8.2
13
9
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
4.2
8.2
29
69
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.6
8.1
189
1186
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
8.1
115
618
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.3
8.1
70
307
V03AE01
ATC
polystyrene sulfonate; oral
3.3
8.1
38
115
FXE00
NOMESCO Finland
Use of ECLA
33.4
8.1
10
*
WW409
NOMESCO Finland
Other aferesis
17.2
8.1
12
7
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
17.2
8.1
12
7
R01
ICPC
Pain respiratory system
3.5
8.1
36
105
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.3
8.1
39
121
B37.0
ICD-10 Finland
Candidal stomatitis
3.9
8.0
31
80
A01AB10
ATC
natamycin; local oral
2.3
8.0
72
322
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
6.3
8.0
20
32
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
4.3
8.0
28
66
XF402
NOMESCO Finland
ECG with work load test
1.5
8.0
285
1980
J01DC02
ATC
cefuroxime; systemic
2.0
8.0
99
506
M35.1
ICD-10 Finland
Other overlap syndromes
7.2
7.9
18
25
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.3
7.9
73
327
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
7.9
899
7553
A12BA01
ATC
potassium chloride; oral
1.8
7.9
136
780
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
7.9
157
942
M02AA07
ATC
piroxicam; topical
1.3
7.9
870
7288
K78
ICPC
Atrial fibrillation/flutter
1.6
7.9
220
1448
-1
NOMESCO Finland
NA
1.3
7.8
587
4659
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
7.8
901
7589
SPAT1059
SPAT
Spirometry at the office
1.9
7.8
118
648
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.7
7.8
25
54
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
4.7
7.8
25
54
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
10.8
7.8
14
13
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
10.8
7.8
14
13
N05AA02
ATC
levomepromazine; systemic
2.2
7.8
78
367
C10AA01
ATC
simvastatin; oral
1.3
7.8
1232
10786
WX213
NOMESCO Finland
Lower leg blockade
4.8
7.7
24
50
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.0
7.7
100
521
J70.3
ICD-10 Finland
Chronic drug-induced interstitial lung disorders
45.1
7.7
9
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
45.1
7.7
9
*
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
15.0
7.7
12
8
RK310
NOMESCO Finland
NA
15.0
7.7
12
8
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
5.0
7.7
23
46
A04AA01
ATC
ondansetron; systemic, rectal
1.8
7.7
132
758
A91
ICPC
Abnormal result investigation NOS
2.0
7.7
99
514
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.1
7.7
88
436
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.9
7.6
29
74
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.6
7.6
51
196
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.4
7.6
26
60
E86
ICD-10 Finland
Volume depletion
2.5
7.6
57
233
293
Kela drug reimbursment
Baricitinib
18.4
7.6
11
6
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
7.6
1005
8600
B07.9
ICD-10 Finland
Verruca simplex
2.4
7.6
62
263
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
8.9
7.5
15
17
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.6
7.5
50
192
R05CB01
ATC
acetylcysteine; inhalant, oral
2.6
7.4
52
204
A12AA04
ATC
calcium carbonate; oral
3.1
7.4
39
129
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
2.1
7.4
80
388
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
80.3
7.4
8
*
5CM18
NOMESCO Finland
NA
7.7
7.4
16
21
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.8
7.4
44
158
132
Kela drug reimbursment
Sarcoidosis
4.6
7.4
24
53
K07
ICPC
Swollen ankles/oedema
1.8
7.4
115
643
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
5.6
7.4
20
36
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.3
1455
13036
212
Kela drug reimbursment
Gout
2.2
7.3
67
303
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
7.3
118
665
B05XA03
ATC
sodium chloride; parenteral
+∞
7.3
7
*
R03DC01
ATC
zafirlukast; oral
2.8
7.3
43
153
J15.2
ICD-10 Finland
Pneumonia due to staphylococcus
+∞
7.3
7
*
J16.8
ICD-10 Finland
Pneumonia due to other specified infectious organisms
+∞
7.3
7
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
7.3
7
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
10.9
7.3
13
12
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
4.2
7.3
26
63
L04AB05
ATC
certolizumab pegol; parenteral
9.4
7.3
14
15
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.7
7.3
45
166
WYA20
NOMESCO Finland
Home visit
2.8
7.3
44
160
Z94.0
ICD-10 Finland
Kidney transplant status
4.5
7.2
24
54
TNG10
NOMESCO Finland
Puncture of knee
3.7
7.2
29
78
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.0
7.2
38
126
3006
Kela drug reimbursment
Baricitinib
15.8
7.2
11
7
E000006
ATC
NA
1.7
7.2
147
891
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.4
7.2
60
258
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
4.3
7.2
25
59
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
7.2
395
2980
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.7
7.2
46
171
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.4
7.2
58
248
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
30.1
7.1
9
*
J43.1
ICD-10 Finland
Panlobular emphysema
30.1
7.1
9
*
4911A
ICD-9 Finland
Chronic bronchitis, Mucopurulent chronic bronchitis
30.1
7.1
9
*
M06
ICD-10 Finland
Other rheumatoid arthritis
4.4
7.1
24
55
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
20.1
7.1
10
5
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.5
7.1
53
214
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.7
7.1
46
173
XJC00
NOMESCO Finland
Oesophageal manometry
6.6
7.1
17
26
ZX140
NOMESCO Finland
Intra articular
5.0
7.1
21
42
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.2
7.1
25
60
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.1
471
3667
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
12.0
7.1
12
10
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.8
7.1
114
643
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
7.1
253
1760
NG1DA
NOMESCO Finland
X-ray of knees
2.7
7.1
46
174
I95.9
ICD-10 Finland
Hypotension, unspecified
2.9
7.1
41
144
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.8
7.1
114
644
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.9
7.0
27
70
WW300
NOMESCO Finland
Transfer of autologic stem cells
8.8
7.0
14
16
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.5
7.0
251
1744
SPAT1211
SPAT
Application of soft bandage
1.6
7.0
196
1292
R03BB07
ATC
umeclidinium bromide; inhalant
4.7
7.0
22
47
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.2
7.0
34
107
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.4
7.0
57
245
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
7.0
7.0
16
23
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
2.9
7.0
40
138
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
4.1
7.0
25
61
EBA10
NOMESCO Finland
Surgical removal of tooth
1.6
7.0
172
1096
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.0
7.0
88
457
M48.0
ICD-10 Finland
Spinal stenosis
1.4
7.0
320
2340
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
2.4
6.9
56
239
L03AA13
ATC
pegfilgrastim; parenteral
2.2
6.9
69
324
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.5
6.9
247
1716
WX402
NOMESCO Finland
General anaesthesia
1.4
6.9
306
2220
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
2.5
6.9
52
214
E66.8
ICD-10 Finland
Other obesity
2.1
6.9
71
339
D01AC02
ATC
miconazole; topical
1.6
6.8
185
1210
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
6.8
387
2935
M01AB55
ATC
diclofenac, combinations; oral
1.6
6.8
172
1102
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
3.4
6.8
31
93
XPX04
NOMESCO Finland
Angioscopy
6.7
6.8
16
24
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
6.7
6.8
16
24
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.4
6.8
52
216
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.0
6.8
20
40
R07.3
ICD-10 Finland
Other chest pain
1.5
6.8
205
1373
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.9
6.8
92
488
Z50.1
ICD-10 Finland
Other physical therapy
1.7
6.8
126
746
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
3.3
6.8
32
99
RS224
NOMESCO Finland
NA
6.1
6.8
17
28
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
5.3
6.8
19
36
WX704
NOMESCO Finland
Intubation
1.7
6.7
139
844
L04AA37
ATC
baricitinib; oral
16.7
6.7
10
6
R49.01
ICD-10 Finland
Functional dysphonia
2.3
6.7
60
269
J01DA08
ATC
[U] cefaclor; oral
1.6
6.7
163
1036
J37.0
ICD-10 Finland
Chronic laryngitis
2.1
6.7
68
324
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.9
6.7
39
138
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.8
6.7
107
603
C02KX04
ATC
macitentan; oral
22.6
6.7
9
*
4040
NOMESCO Finland
NA
22.6
6.7
9
*
5163A
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis
22.6
6.7
9
*
J01XX08
ATC
linezolid; systemic
4.9
6.7
20
41
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.7
6.6
130
781
I20.09
ICD-10 Finland
Unstable angina
1.6
6.6
161
1026
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
6.6
256
1810
S29
ICPC
Skin symptom/complaint other
1.4
6.6
366
2762
K76.9
ICD-10 Finland
Liver disease, unspecified
3.1
6.6
34
112
R03BB05
ATC
aclidinium bromide; inhalant
7.8
6.6
14
18
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
5.9
6.6
17
29
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.6
6.6
165
1060
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.1
6.6
33
107
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
6.6
373
2831
L17
ICPC
Foot/toe symptom/complaint
1.3
6.6
529
4235
N30.0
ICD-10 Finland
Acute cystitis
1.4
6.5
266
1902
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.0
6.5
34
113
S22.2
ICD-10 Finland
Fracture of sternum
4.3
6.5
22
51
R63.4
ICD-10 Finland
Abnormal weight loss
1.9
6.5
84
441
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.7
6.5
26
71
C08CA02
ATC
felodipine; oral
1.4
6.4
262
1871
R03AC19
ATC
olodaterol; inhalant
5.7
6.4
17
30
-44
ICPC
Preventive immunization/medic
1.5
6.4
214
1465
XX1VW
NOMESCO Finland
Written report from radiologist
4.3
6.4
22
52
J98.1
ICD-10 Finland
Pulmonary collapse
4.3
6.4
22
52
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
7.4
6.4
14
19
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.6
6.4
144
900
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
6.4
77
394
SPAT1251
SPAT
Organisation of medication
1.9
6.4
83
436
C07AB02
ATC
metoprolol; systemic
1.3
6.4
588
4791
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.4
901
7737
J11.0
ICD-10 Finland
Influenza with pneumonia, virus not identified
8.2
6.3
13
16
E66.00
ICD-10 Finland
Metabolic syndrome
1.8
6.3
98
545
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.6
6.3
43
169
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
3.0
6.3
34
116
RK520
NOMESCO Finland
NA
5.2
6.3
18
35
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
6.3
72
361
R03DX07
ATC
roflumilast; oral
11.0
6.3
11
10
348
Kela drug reimbursment
Roflumilast
11.0
6.3
11
10
L04AC07
ATC
tocilizumab; parenteral
9.3
6.3
12
13
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
9.3
6.3
12
13
S20
ICPC
Corn/callosity
2.4
6.3
51
218
J93.9
ICD-10 Finland
Pneumothorax, unspecified
4.6
6.3
20
44
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.3
1035
9032
ECB20
NOMESCO Finland
Oral alveoplasty
3.7
6.3
25
68
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.8
6.3
103
585
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
+∞
6.2
6
*
J15.6
ICD-10 Finland
Pneumonia due to other Gram-negative bacteria
+∞
6.2
6
*
J14
ICD-10 Finland
Pneumonia due to Haemophilus influenzae
+∞
6.2
6
*
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
3.1
6.2
31
100
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.7
6.2
119
708
GDB01
NOMESCO Finland
Thoracoscopic resection of bullae of lung
26.7
6.2
8
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
26.7
6.2
8
*
R51.80
ICD-10 Finland
Headache
1.5
6.2
233
1639
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.7
6.2
112
657
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
7.0
6.2
14
20
RK290
NOMESCO Finland
NA
7.0
6.2
14
20
W19
ICD-10 Finland
Unspecified fall
1.5
6.2
188
1263
GD1LA
NOMESCO Finland
GD
2.6
6.2
42
165
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
6.2
61
285
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.5
6.2
26
74
HA1AA
NOMESCO Finland
X-ray mammography
1.7
6.2
132
813
GBB00
NOMESCO Finland
Tracheostomy
3.1
6.2
31
101
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.8
6.2
36
128
G53.0
ICD-10 Finland
Postzoster neuralgia
3.6
6.2
25
69
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.9
6.2
85
454
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
6.2
108
629
WVA20
NOMESCO Finland
Medicine administration
2.3
6.1
51
222
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.2
6.1
59
275
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
6.1
205
1409
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.9
6.1
79
414
SXC03
NOMESCO Finland
Other oral or dental procedure
3.4
6.1
27
80
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
3.5
6.1
26
75
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
6.1
252
3374
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.0
6.1
70
351
B37.08
ICD-10 Finland
Other candidal stomatitis
4.0
6.1
22
55
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
12.5
6.1
10
8
N18.0
ICD-10 Finland
End-stage renal disease
3.0
6.1
32
108
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
6.1
695
5815
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
8.6
6.0
12
14
S20.2
ICD-10 Finland
Contusion of thorax
1.8
6.0
98
557
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
6.0
94
526
L04AA29
ATC
tofacitinib; oral
10.0
6.0
11
11
M31.7
ICD-10 Finland
Microscopic polyangiitis
10.0
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
246
125
21.27
322.70
2.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2194
11001
4.31
320.21
15.0
5.3
%
22.8
27.0
53.83
2143
10064
(3018010) Neutrophils/100 leukocytes in Blood
2168
10843
4.24
316.00
14.2
5.1
%
62.5
57.6
58.37
2114
9984
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
622
227
33.93
307.65
2.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
523
183
34.10
307.65
2.2
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
2309
11891
4.57
307.65
14.8
5.1
e9/l
0.2
0.2
0.14
2150
10173
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1059
2861
5.08
307.65
10.0
6.3
kpa
5.1
5.0
0.23
1015
2734
(3019198) Lymphocytes [#/volume] in Blood
2289
11747
4.51
307.65
13.9
5.0
e9/l
1.8
1.9
0.35
2124
10091
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1203
2575
6.96
307.65
2.8
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
447
166
31.24
307.65
1.9
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
545
897
7.14
307.65
2.6
1.7
ug/l
2.3
2.6
0.11
496
753
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
523
262
23.76
307.65
2.5
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
241
84
30.99
307.65
2.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1948
6633
6.11
307.65
7.1
3.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
2187
10733
4.43
307.65
14.7
5.1
%
2.5
2.9
18.66
2138
9848
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1490
3784
6.60
307.65
3.1
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1075
2572
5.84
307.65
1.6
1.3
titre
573.1
510.3
0.47
309
563
(3009445) Proteinase 3 Ab [Units/volume] in Serum
727
916
10.03
307.65
1.8
1.6
u/ml
17.4
17.0
0.02
21
29
(3023419) Bacteria identified in Sputum by Culture
425
187
26.13
307.65
3.1
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2282
11456
4.64
307.65
13.7
4.9
e9/l
0.7
0.6
33.39
2099
9665
(3003396) Base excess in Arterial blood by calculation
1050
2864
5.01
307.65
10.1
6.3
mmol/l
1.7
0.7
9.57
881
2180
(3006315) Basophils [#/volume] in Blood
2284
11528
4.61
307.65
13.7
4.9
e9/l
0.0
0.0
1.30
2106
9738
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
821
686
15.86
307.65
3.4
2.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
291
156
20.46
307.65
3.5
3.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
655
351
23.32
307.65
2.5
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
469
204
26.86
307.65
1.9
1.2
—
—
—
0
0
(44790049)
331
160
23.01
307.65
2.6
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
249
35
77.19
307.65
1.9
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
672
363
23.29
307.65
2.4
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
223
72
33.27
307.65
2.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
344
280
13.68
307.65
3.6
2.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
835
1617
6.67
307.65
5.6
4.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
401
164
27.89
307.65
2.7
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
542
83
78.73
307.65
2.3
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
457
197
26.98
307.65
2.5
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2191
10782
4.42
307.65
15.2
5.4
%
8.8
9.0
2.77
2141
9935
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
425
306
15.91
307.65
11.6
4.4
iu/ml
1894.6
535.8
0.46
101
32
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
324
257
13.94
307.65
1.2
1.1
—
—
—
0
0
(44806118)
331
160
23.01
307.65
2.6
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
624
415
18.52
307.65
2.1
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
222
71
33.57
307.65
2.3
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
2176
10436
4.54
307.65
14.5
5.2
%
0.6
0.7
18.90
2130
9593
(44790047)
331
160
23.01
307.65
2.6
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1206
2545
7.07
307.65
2.9
1.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
1057
2859
5.07
307.65
10.0
6.3
kpa
9.8
12.6
71.19
1014
2731
(3005719) IgG [Mass/volume] in Serum or Plasma
755
1467
6.46
307.65
4.6
2.5
g/l
10.0
10.8
2.86
726
1324
(44790048)
331
160
23.01
307.65
2.6
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1880
7929
4.42
307.65
13.5
5.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
526
691
8.94
307.65
2.0
1.5
titre
339.2
186.3
0.70
39
35
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
193
63
32.58
297.79
1.5
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
289
241
13.11
292.44
5.3
2.6
u/ml
791.2
2798.9
0.78
29
20
(3028026) IgM [Mass/volume] in Serum or Plasma
591
1174
5.97
291.81
2.3
1.8
g/l
1.1
1.5
3.51
551
1060
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
242
151
17.28
288.01
2.1
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
325
335
10.71
285.60
1.7
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
246
168
15.80
279.20
2.1
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
408
583
7.90
276.67
2.0
1.3
iu/ml
13.7
9.8
—
24
9
(3000494) Fungus identified in Specimen by Culture
866
2511
4.38
270.66
2.5
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
880
2632
4.26
263.05
11.0
6.5
%
93.2
95.9
18.84
847
2532
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
339
421
8.91
258.21
1.5
1.2
titre
223.5
127.5
—
17
8
(3006184) Hemoglobin [Mass/volume] in Capillary blood
382
547
7.81
258.10
2.8
2.0
g/l
126.4
128.7
0.61
188
406
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
152
35
45.59
257.20
1.4
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
573
1266
5.31
249.56
11.1
8.3
mmol/l
24.8
24.0
6.06
534
1173
(3013650) Neutrophils [#/volume] in Blood by Automated count
2322
13546
3.75
238.45
18.5
7.6
e9/l
5.1
4.1
60.28
2174
11638
(3042936) Bacteria identified in Isolate by Culture
976
3347
3.78
237.38
2.8
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
739
2175
4.14
222.49
1.6
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
169
87
20.47
219.69
4.6
2.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
395
708
6.24
214.62
1.3
1.2
u/ml
1.3
0.6
0.48
39
72
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
278
339
8.90
214.15
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
278
339
8.90
214.15
1.6
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
209
172
12.95
212.38
1.4
1.1
u/ml
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
339
527
7.09
211.60
1.9
1.4
g/l
0.2
0.2
0.56
324
498
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
170
97
18.47
210.76
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
324
490
7.26
207.38
6.2
3.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
664
1927
4.10
202.38
6.8
3.6
%
0.9
0.9
0.03
289
492
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
339
553
6.75
201.93
1.9
1.4
g/l
1.2
1.2
1.09
327
521
(3005322) IgE [Units/volume] in Serum or Plasma
453
980
5.23
200.21
1.7
1.2
u/ml
209.8
216.7
0.06
419
900
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
105
14
77.56
196.02
3.1
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
183
146
13.25
189.31
1.2
1.3
g/l
7.8
6.9
0.87
126
98
(3024139) IgG subclass 3 [Mass/volume] in Serum
183
146
13.25
189.31
1.2
1.3
g/l
0.5
0.5
0.08
126
98
(3028192) IgG subclass 2 [Mass/volume] in Serum
183
146
13.25
189.31
1.2
1.3
g/l
2.8
3.0
0.37
127
99
(3024980) IgG subclass 4 [Mass/volume] in Serum
228
254
9.60
188.09
1.6
1.7
g/l
0.8
1.0
0.34
164
198
(3002179) Metamyelocytes/100 leukocytes in Blood
610
1751
4.08
187.82
6.6
3.5
%
0.5
0.6
0.16
229
352
(4062490)
182
147
13.08
186.85
1.2
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
534
1395
4.41
186.61
11.8
6.3
mmol/l
25.3
24.5
3.74
525
1385
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
177
137
13.63
186.42
1.7
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
177
137
13.63
186.42
1.7
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
177
137
13.63
186.42
1.7
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
182
151
12.73
183.77
2.5
2.3
e9/l
1.0
1.1
0.83
134
75
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
576
1620
4.13
182.08
2.0
1.5
—
—
—
0
0
(3000492) Spirometry study
596
1734
4.01
179.58
3.0
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
966
3847
3.18
178.38
7.2
2.8
mmol/l
0.8
0.8
2.37
899
3555
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
904
3465
3.26
178.08
1.4
1.2
iu/ml
58.8
37.1
2.67
335
1048
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
544
1490
4.21
178.06
6.8
3.3
mmol/l
2.5
1.5
7.14
452
1046
(3009343) pH of Capillary blood
555
1550
4.14
176.84
7.0
3.3
ph
7.4
7.4
3.58
110
184
(3002173) Hemoglobin [Mass/volume] in Arterial blood
722
2420
3.58
176.33
12.4
6.7
g/l
121.6
120.1
1.06
699
2334
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2004
11866
2.91
176.22
11.4
5.3
mmol/l
1.2
1.2
12.49
1896
10584
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
558
1572
4.10
175.61
7.0
3.3
kpa
5.2
5.1
0.96
531
1434
(3018418) pH of Serum or Plasma
1496
7657
2.82
173.50
6.3
3.5
ph
7.4
7.4
0.65
377
1386
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
333
626
5.83
171.14
2.0
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2098
12872
2.90
169.74
10.9
5.8
umol/l
11.2
12.8
5.98
2031
12158
(1175426) CD3 cells/100 lymphocytes in Blood
154
110
14.67
169.74
2.4
2.4
%
71.5
69.7
0.41
148
101
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
152
107
14.88
168.89
2.4
2.4
%
16.8
14.9
0.38
56
42
(3021440) Promyelocytes/100 leukocytes in Blood
604
1850
3.80
168.34
7.0
3.6
%
0.1
0.1
0.16
273
454
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
147
101
15.22
165.50
2.5
2.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
124
61
21.12
164.05
2.2
1.8
u/ml
67932.1
67676.3
—
20
7
(3027315) Oxygen [Partial pressure] in Blood
287
498
6.24
160.05
8.3
3.5
kpa
8.0
8.5
5.66
279
487
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
249
374
7.15
159.64
5.4
3.3
%
61.1
57.7
2.70
249
374
(3020779) Urea [Moles/volume] in Serum or Plasma
668
2267
3.47
158.61
12.4
6.1
mmol/l
11.4
10.7
1.61
635
2132
(3013290) Carbon dioxide [Partial pressure] in Blood
285
496
6.22
158.43
8.3
3.5
kpa
5.0
4.9
1.38
277
485
(3012501) Base excess in Blood by calculation
285
496
6.22
158.43
8.3
3.5
mmol/l
3.0
2.5
1.63
222
305
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2094
13129
2.79
157.04
12.5
5.9
mmol/l
1.2
1.2
5.42
1758
10997
(4010399)
543
1619
3.85
156.70
2.2
1.4
—
—
—
0
0
(3010421) pH of Blood
309
589
5.71
156.14
8.1
3.5
ph
7.4
7.4
0.42
277
486
(3015235) Bicarbonate [Moles/volume] in Capillary blood
317
627
5.51
153.80
5.7
2.7
mmol/l
25.6
24.6
2.66
292
543
(3028626) Oxygen [Partial pressure] in Capillary blood
298
558
5.80
153.42
6.4
3.2
kpa
7.6
8.2
7.66
286
516
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
833
3293
3.08
152.85
1.3
1.2
u/ml
33.0
13.4
2.02
258
1182
(3025159) Blasts/100 leukocytes in Blood
562
1746
3.70
152.41
7.0
3.6
%
0.1
0.4
0.89
241
390
(40767503) Oxygen content in Capillary blood by calculation
283
518
5.91
149.16
4.0
2.0
%
15.5
16.2
1.55
158
270
(3021901) Oxygen saturation in Capillary blood
264
453
6.27
148.70
5.4
2.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1050
4790
2.79
147.16
2.8
1.7
mg/l
1.8
1.4
1.40
901
3686
(21494815) CD4 cells/100 lymphocytes in Specimen
145
123
12.31
144.11
2.4
2.3
%
32.7
47.0
—
7
20
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1564
8755
2.57
143.59
4.7
2.9
ng/l
2181.1
1574.3
5.00
1433
7550
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
368
875
4.63
143.54
1.7
1.7
u/l
37.2
39.0
0.82
331
744
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
254
437
6.24
142.58
1.3
1.2
u/ml
8.3
6.9
0.10
22
33
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
277
519
5.76
142.30
1.4
1.2
u/ml
16.7
3.9
0.74
32
43
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
278
525
5.71
141.60
1.4
1.2
u/ml
13.8
6.9
0.69
50
83
(3000991) Gas panel - Venous blood
606
2081
3.37
139.87
12.1
6.9
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
282
552
5.51
138.08
1.4
1.2
u/ml
39.9
34.6
0.10
14
31
(3001964) Herpes simplex virus Ag [Presence] in Specimen
96
39
25.36
136.84
2.9
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
301
630
5.18
136.65
1.8
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
213
324
6.98
134.65
1.4
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
558
1861
3.43
134.61
2.1
2.1
nmol/l
342.4
379.3
2.59
521
1697
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
464
1378
3.78
133.56
1.8
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
1071
5154
2.64
132.61
4.3
2.7
mosm/kgh2o
530.3
558.1
4.87
974
4346
(3014111) Lactate [Moles/volume] in Serum or Plasma
608
2192
3.20
128.71
11.3
6.0
mmol/l
1.5
1.4
1.70
580
2114
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
264
519
5.46
128.48
1.8
1.9
mg/l
11.2
11.4
0.15
244
469
(40760892) CBC W Ordered Manual Differential panel - Blood
989
4641
2.65
128.20
10.4
4.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1423
7931
2.45
127.62
5.6
3.3
e6/l
121.5
90.7
0.15
1197
6121
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
745
3027
2.92
127.61
4.9
3.8
u/l
274.0
246.1
3.51
709
2829
(3000850) Epithelial cells [#/volume] in Urine
1112
5534
2.56
127.50
4.2
2.5
e6/l
4.9
4.5
0.48
1029
4846
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
196
290
7.14
127.04
1.4
1.4
u/ml
145.5
128.2
0.19
35
56
(3008152) Bicarbonate [Moles/volume] in Arterial blood
505
1638
3.48
126.85
10.6
6.0
mmol/l
25.3
24.2
7.87
481
1523
(40757373) Influenza virus identified in Isolate
84
29
29.73
126.57
2.7
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
772
3226
2.85
125.24
8.8
4.9
mmol/l
1.1
1.0
1.73
715
2972
(36304419) Bacteria [Presence] in Urine
1295
6964
2.46
125.10
5.2
3.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
641
2431
3.06
123.99
5.3
3.2
mmol/l
2.5
1.7
5.13
533
1935
(3021589) Normoblasts [#/volume] in Blood
1690
10262
2.40
123.75
23.1
9.1
e9/l
0.0
0.0
0.28
1470
8370
(40758558) Short blood count panel - Blood
1134
5773
2.51
123.05
13.1
5.9
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
100
58
17.78
122.56
46.3
22.8
ug/l
156.3
116.5
2.96
81
48
(3021447) Carbon dioxide [Partial pressure] in Venous blood
635
2441
3.01
119.56
5.3
3.2
kpa
6.0
5.8
3.94
606
2374
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
92
47
20.14
119.51
2.2
2.5
—
—
—
0
0
(3012544) pH of Venous blood
648
2525
2.97
119.03
5.3
3.2
ph
7.4
7.4
—
7
17
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
263
551
5.12
118.93
1.6
1.6
iu/ml
13.5
16.2
0.06
61
108
(3030467) Casts [#/volume] in Urine by Automated count
1311
7248
2.39
117.18
5.3
3.1
e6/l
0.4
0.5
0.74
1086
5506
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
267
574
4.99
117.12
3.4
2.5
g/l
4.0
3.4
5.00
259
543
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1284
7059
2.39
115.96
5.7
2.9
u/l
35.1
36.1
0.16
1233
6651
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
108
81
13.77
115.49
1.8
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
108
81
13.77
115.49
1.8
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
108
81
13.77
115.49
1.8
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
822
3721
2.64
112.60
2.1
1.4
g/l
2.8
2.6
1.13
614
2112
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
631
2495
2.91
112.30
5.0
2.8
ng/l
266.3
216.0
1.96
591
2280
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
106
81
13.51
112.10
1.8
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1771
11275
2.31
112.09
7.4
4.3
g/l
32.4
35.2
69.18
1656
10385
(3024891) Influenza virus A+B Ag [Presence] in Specimen
201
347
6.12
112.07
1.4
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
79
33
24.53
111.30
4.3
4.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1514
9049
2.30
111.17
6.7
3.7
e6/l
86.4
106.3
0.26
1228
6573
(3017143) Hepatitis C virus Ab [Presence] in Serum
509
1797
3.19
110.51
1.6
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
93
59
16.21
108.93
2.2
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
331
891
4.04
108.75
4.2
2.9
u/ml
0.3
0.3
0.94
201
508
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
786
3552
2.62
107.43
3.2
2.4
%
19.5
22.7
9.46
663
2989
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
93
62
15.43
106.13
1.8
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
93
62
15.43
106.13
1.8
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
93
62
15.43
106.13
1.8
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
425
1384
3.40
105.09
15.4
8.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
811
3781
2.54
103.40
3.1
2.3
g/l
2.2
2.3
4.99
753
3472
(3032080) INR in Blood by Coagulation assay
1749
11321
2.23
103.03
14.9
10.0
inr
1.3
1.3
1.34
608
3013
(3021879) Hepatitis B virus core Ab [Presence] in Serum
375
1143
3.59
102.70
1.4
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
850
4079
2.49
101.64
3.2
2.3
umol/l
10.5
12.9
21.47
801
3746
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
524
1972
2.99
101.25
1.6
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
89
60
15.24
100.93
1.2
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2414
17969
2.49
100.37
10.6
3.9
mm/h
20.6
12.9
73.33
2348
16346
(3014576) Chloride [Moles/volume] in Serum or Plasma
735
3338
2.57
98.46
12.9
5.8
mmol/l
103.5
104.6
6.11
711
3268
(3013826) Glucose [Moles/volume] in Serum or Plasma
2130
15119
2.27
97.42
10.4
4.2
mmol/l
6.9
6.8
1.47
2056
14197
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
104
97
11.05
96.93
1.5
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
985
5155
2.33
96.03
5.8
3.7
ng/l
427.3
631.7
0.51
890
4403
(3022313) Gas panel - Capillary blood
360
1135
3.45
93.25
7.4
3.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
364
1160
3.42
92.69
4.9
3.4
mmol/l
24.6
23.9
3.22
334
1021
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
107
111
9.94
92.55
2.4
2.1
e6/l
491.0
468.9
0.15
90
89
(3008536) Aspergillus sp Ab [Presence] in Serum
64
26
25.11
90.98
1.8
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
558
2294
2.74
90.73
2.2
2.2
g/l
65.3
66.5
2.85
517
2047
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
441
1598
3.05
90.56
2.2
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
128
176
7.54
88.36
1.5
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
148
239
6.45
88.02
1.3
1.2
u/ml
70.0
41.4
0.52
16
14
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
94
88
10.98
87.35
1.7
1.2
u/ml
1.9
1.8
0.02
63
40
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
238
594
4.25
86.18
3.6
2.4
%
90.6
87.7
1.05
227
560
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
99
104
9.80
84.81
2.6
2.1
e9/l
0.2
0.2
0.08
89
87
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
155
272
5.94
84.77
1.2
1.2
u/ml
358.3
254.2
2.58
101
160
(3004588) Protein electrophoresis panel - Serum or Plasma
491
1961
2.78
83.99
2.0
2.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
71
45
16.12
83.08
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
72
47
15.66
82.97
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
180
370
5.10
82.80
1.4
1.2
u/ml
63.1
48.7
0.44
29
38
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
160
298
5.60
82.15
1.2
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
77
58
13.58
81.99
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
77
58
13.58
81.99
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
77
58
13.58
81.99
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
77
58
13.58
81.99
1.1
1.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2461
19143
2.33
81.56
16.4
6.9
u/l
79.9
80.8
0.42
2408
17823
(3023420) DNA double strand Ab [Units/volume] in Serum
123
179
7.11
80.67
2.2
1.2
iu/ml
20.0
27.6
—
9
8
(3033658) Prothrombin time (PT) actual/Normal
1068
6164
2.11
78.66
7.1
3.7
%
84.3
85.1
0.39
1047
6010
(3048929) Epstein Barr virus Ab [Presence] in Serum
182
397
4.81
78.02
1.2
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
690
3350
2.36
77.85
4.0
2.2
%
2.0
1.7
6.66
617
2900
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
105
137
7.90
75.79
1.3
1.2
titre
164.5
113.2
0.32
22
28
(3031040) Bacteria [#/volume] in Urine by Automated count
2187
16490
2.08
74.57
7.2
4.6
e6/l
727.6
2224.4
1.37
44
262
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
211
540
4.12
73.71
3.7
2.5
%
227.2
198.0
3.73
200
510
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
414
1630
2.77
72.19
15.4
7.6
%
0.7
0.7
0.31
408
1618
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
414
1646
2.75
70.77
15.3
7.5
%
1.4
1.3
2.06
408
1634
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
83
88
9.66
70.58
2.4
2.8
%
37.9
35.6
0.28
39
31
(3004809) Band form neutrophils/100 leukocytes in Blood
165
362
4.76
70.17
4.5
3.3
%
1.7
1.3
0.57
144
264
(3037467) Urinalysis macro (dipstick) panel - Urine
2216
16977
2.04
69.69
7.6
4.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
476
2059
2.55
68.52
4.4
2.7
kpa
4.4
4.4
0.03
454
2000
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
137
263
5.40
67.98
1.4
1.2
u/ml
6.9
2.8
0.42
48
84
(3018677) aPTT in Platelet poor plasma by Coagulation assay
775
4154
2.15
67.60
3.1
1.9
s
29.9
30.0
0.28
755
4015
(3007853) Bacteria identified in Skin by Aerobe culture
566
2668
2.37
67.42
2.3
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
248
761
3.45
66.43
10.2
5.6
mmol/l
1.4
1.3
0.99
225
675
(3004616) Nuclear Ab [Presence] in Serum
139
276
5.22
66.42
1.3
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
132
251
5.45
66.18
1.4
1.2
u/ml
2.4
4.6
1.35
74
108
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
510
2322
2.43
65.54
2.2
2.1
g/l
0.2
0.2
0.02
471
2160
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1112
6873
1.96
64.99
2.7
2.2
mg/l
3.4
3.1
3.17
988
5750
(3017569) Oxygen content in Arterial blood
90
120
7.69
63.74
2.3
1.9
—
—
—
0
0
(4306422)
128
245
5.40
63.70
1.3
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
88
116
7.78
62.93
2.5
1.9
e6/l
723.8
624.9
0.50
39
56
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
307
1106
2.97
62.79
7.5
4.5
%
1.8
1.6
2.91
287
1043
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
556
2677
2.31
62.69
5.6
3.2
—
—
—
0
0
(3036489) Thrombin time
247
789
3.31
61.99
3.5
2.0
s
21.7
21.8
0.04
225
707
(3019977) pH of Arterial blood
93
133
7.18
61.91
2.8
2.2
ph
7.4
7.4
0.11
54
44
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
763
4188
2.09
61.79
4.6
3.0
e6/l
1.9
2.0
0.26
443
2355
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
98
149
6.76
61.66
2.3
2.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
228
695
3.46
61.63
1.5
1.2
—
—
—
0
0
(4015189)
60
48
12.72
61.56
2.7
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
96
144
6.85
61.17
1.1
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1441
9836
1.86
61.02
3.0
2.1
nmol/l
77.7
79.3
1.32
1323
8543
(3006245) CD3-CD19+ cells/100 cells in Blood
60
49
12.46
60.79
2.6
2.4
%
9.9
14.1
0.64
54
41
(3026493) Urate [Moles/volume] in Serum or Plasma
1066
6657
1.91
59.20
5.6
2.6
umol/l
2499.0
7067.1
4.25
941
5606
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1480
10258
1.84
59.01
6.2
3.8
ng/l
152.7
55.2
0.42
1236
7870
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
104
176
6.08
58.94
1.2
1.1
u/ml
49.5
2.6
—
6
8
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
334
1310
2.73
58.15
1.9
1.5
g/l
1.7
1.5
3.38
285
1100
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
106
187
5.83
57.56
1.2
1.1
u/ml
31.2
63.2
—
5
17
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
158
393
4.18
57.21
1.3
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
40
16
25.31
56.95
1.4
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
121
244
5.12
56.78
1.3
1.1
%
118.1
114.7
0.43
116
218
(3007930) Methemoglobin/Hemoglobin.total in Blood
291
1091
2.84
55.13
7.9
4.6
%
0.8
0.9
0.51
271
1030
(3037756) Immunofixation for Serum or Plasma
196
583
3.52
54.94
1.4
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1304
8835
1.81
54.78
4.7
3.1
mmol/l
2.3
2.4
6.61
1169
7515
(3038026) Centromere Ab [Units/volume] in Serum
106
196
5.56
54.76
1.2
1.1
u/ml
32.3
64.0
—
5
7
(3009871) Measles virus Ab [Titer] in Serum
52
40
13.20
54.58
1.4
1.6
—
—
—
0
0
(3039000) Anion gap in Blood
189
556
3.55
53.87
10.3
6.4
mmol/l
11.8
11.3
0.90
172
500
(3018572) Chloride [Moles/volume] in Blood
189
556
3.55
53.87
10.3
6.4
mmol/l
103.7
105.5
5.98
172
500
(3014148) Varicella zoster virus Ab [Titer] in Serum
93
154
6.19
53.86
1.2
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
520
2582
2.22
53.79
3.9
2.2
e9/l
75.0
67.2
3.74
373
1964
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1566
11269
1.78
53.10
3.3
2.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
118
247
4.92
53.01
1.2
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1383
9626
1.78
52.34
3.7
2.7
ug/l
230.3
148.3
9.12
1281
8688
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
458
2183
2.29
52.21
5.9
3.4
mmol/l
1.2
1.2
3.56
433
1868
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1204
8058
1.80
51.96
3.8
2.1
u/l
166.1
210.8
1.14
1140
7510
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
154
404
3.96
51.84
1.1
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1195
7985
1.80
51.81
4.0
3.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
82
127
6.60
50.69
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
82
127
6.60
50.69
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
82
127
6.60
50.69
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
164
457
3.73
50.65
2.0
1.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
108
218
5.10
50.61
1.5
1.4
mmol/l
6.6
6.2
0.51
99
206
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
514
2605
2.16
50.25
3.1
2.5
umol/l
8.9
9.8
0.38
447
2292
(3020891) Body temperature
273
1041
2.78
49.97
6.9
4.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
98
184
5.47
49.79
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
35
14
25.27
49.75
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
82
130
6.45
49.56
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
82
130
6.45
49.56
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
82
130
6.45
49.56
1.3
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
239
855
2.94
49.23
3.6
2.1
ug/l
361.8
792.3
1.04
229
814
(3035350) Ketones [Presence] in Urine by Test strip
1605
11815
1.73
48.64
5.4
3.7
estimate
0.0
0.0
0.00
466
2153
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1137
7634
1.77
47.46
3.1
2.4
u/l
61.9
60.1
0.13
1062
6971
(4268621)
93
174
5.48
47.43
2.4
2.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
98
195
5.16
46.68
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
210
721
3.05
46.48
4.8
3.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
70
102
7.00
45.80
1.1
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1610
11996
1.70
45.52
5.5
3.8
estimate
0.0
0.0
1.08
456
2093
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
98
201
5.00
45.08
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1591
11837
1.70
45.05
7.3
5.0
estimate
0.0
0.0
0.50
472
2155
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
753
4524
1.87
44.99
4.3
2.8
e6/l
0.9
1.3
2.28
434
2660
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
255
992
2.71
44.80
8.8
3.6
mmol/l
25.3
24.6
3.73
246
892
(3003434) Protein [Mass/volume] in Pleural fluid
129
333
4.00
44.38
1.6
1.5
g/l
32.2
30.8
0.54
114
307
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
89
171
5.33
44.09
1.3
1.3
u/l
15.7
12.8
0.48
80
162
(4035726)
432
2152
2.17
43.73
1.4
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
257
1023
2.65
43.11
2.3
1.9
g/l
10.6
10.2
0.63
219
852
(3034860) Kappa light chains.free [Mass/volume] in Serum
236
900
2.75
43.06
2.6
2.7
mg/l
63.7
117.8
0.41
167
739
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
102
226
4.63
42.80
1.4
1.3
u/l
503.0
302.6
1.71
94
214
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
234
897
2.74
42.26
2.6
2.7
mg/l
50.7
64.2
0.38
164
741
(40761536) Microorganisms panel - Urine sediment
406
2001
2.18
42.13
6.0
3.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
266
1090
2.57
42.04
2.2
1.9
g/l
3.8
3.8
0.06
204
758
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
266
1091
2.57
41.96
2.2
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
266
1091
2.57
41.96
2.2
1.9
g/l
8.0
7.3
5.55
208
790
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
252
1009
2.63
41.75
2.3
2.0
g/l
3.4
3.0
5.21
207
781
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
229
875
2.74
41.60
2.6
2.7
ratio
3.6
2.3
0.38
16
70
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
254
1029
2.60
41.07
3.0
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
304
1350
2.39
40.36
5.5
2.9
mmol/l
25.8
25.0
3.14
283
1309
(3018405) Lactate [Moles/volume] in Arterial blood
235
928
2.66
40.00
5.6
3.4
mmol/l
1.4
1.4
0.01
230
914
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
214
808
2.77
39.75
2.2
1.9
g/l
0.1
0.0
0.27
199
730
(3034426) Prothrombin time (PT)
50
58
8.74
39.65
1.1
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
353
1688
2.23
39.36
5.7
2.9
g/l
123.8
128.2
3.25
338
1644
(3015736) pH of Urine
1273
9193
1.65
38.36
4.5
3.5
—
5.8
—
0
11
(3008757) Leukocyte morphology finding [Identifier] in Blood
103
251
4.21
38.30
5.3
3.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
200
750
2.78
37.62
2.2
1.9
g/l
0.0
0.0
0.50
185
676
(3012441) Differential panel - Pleural fluid
103
256
4.13
37.31
1.7
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
217
854
2.66
37.15
2.2
1.9
g/l
35.5
37.9
6.09
196
710
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
110
288
3.92
37.11
8.8
6.8
mg/l
12.0
12.3
0.27
101
269
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
230
932
2.58
37.11
2.2
2.1
g/l
0.6
1.1
1.45
205
783
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
196
736
2.77
36.76
2.2
2.0
g/l
0.0
0.0
0.00
185
674
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
61
98
6.33
36.40
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
184
673
2.84
36.26
2.6
2.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
249
1061
2.46
36.12
1.4
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
95
229
4.25
35.84
1.7
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
137
435
3.25
34.55
1.7
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
108
294
3.77
34.49
1.7
1.4
e6/l
5865.6
1621.5
0.70
78
216
(3023183) Ammonium ion [Moles/volume] in Plasma
144
472
3.15
34.44
2.6
2.5
umol/l
33.0
34.7
0.38
125
385
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
63
121
5.29
31.25
2.2
1.6
u/l
6.3
6.9
0.23
57
108
(3035880) pH of Pleural fluid
64
125
5.21
31.16
1.3
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2226
18893
1.61
31.12
47.2
17.9
%
14.6
13.8
90.87
2203
18415
(3046861) Legionella sp Ag [Presence] in Urine
36
6
60.66
31.09
1.1
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
843
5738
1.64
30.59
2.0
1.8
nmol/l
1210.1
1155.4
0.81
642
4227
(3028308) Erythrocytes [#/volume] in Pleural fluid
97
270
3.68
30.01
1.6
1.3
e6/l
104212.1
102068.4
0.01
58
156
(40768806) Pleura Pathology biopsy report
95
262
3.71
29.79
1.7
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
133
454
3.01
29.68
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
386
2114
1.94
29.53
2.8
2.3
u/l
35.5
39.8
0.76
354
1815
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
156
583
2.76
29.50
3.8
2.8
mg/l
1.8
1.6
2.26
144
514
(3000060) B lymphocytes [#/volume] in Blood
34
36
9.54
28.85
2.9
2.2
e6/l
1268.3
388.0
—
18
10
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
218
969
2.34
28.69
2.6
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
60
123
4.95
27.67
6.5
3.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
264
1290
2.14
27.60
4.7
2.4
%
1.3
1.1
3.37
264
1281
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
168
683
2.54
26.86
1.5
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
34
40
8.58
26.64
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
872
6157
1.58
26.51
5.7
3.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
35
43
8.22
26.50
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
55
109
5.12
26.37
4.2
3.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
29
28
10.44
26.24
1.6
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
40
59
6.85
25.89
2.4
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
354
1965
1.90
25.86
4.5
3.4
ng/l
107.0
90.5
2.02
306
1660
(3004451) EKG impression Narrative
61
135
4.59
25.69
1.4
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
25
20
12.59
25.48
1.4
1.1
ng/l
90.7
22.9
—
17
10
(3044242) Glucose [Moles/volume] in Arterial blood
61
137
4.52
25.23
1.8
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
30
33
9.17
24.73
1.6
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
20
11
18.29
24.73
1.2
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
901
6523
1.53
24.06
6.1
4.1
estimate
0.0
0.0
0.88
431
2047
(3040151) Glucose [Moles/volume] in Capillary blood
93
292
3.25
23.93
17.6
6.6
mmol/l
7.6
7.5
0.09
83
236
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
734
5103
1.57
23.40
3.1
2.9
mmol/l
2.5
2.5
10.50
650
4468
(3043409) Potassium [Moles/volume] in Arterial blood
179
801
2.31
23.16
6.8
3.6
mmol/l
4.0
3.9
0.81
159
748
(40768446) Kidney Pathology biopsy report
38
60
6.40
23.08
1.4
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
94
308
3.12
22.55
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
159
684
2.40
22.51
1.7
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
795
5680
1.54
22.27
4.5
3.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
53
118
4.55
22.18
2.4
2.2
mmol/l
8.1
9.5
1.85
46
96
(3024928) Oxygen saturation in Venous blood
131
519
2.59
22.10
4.4
2.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
88
283
3.17
21.79
1.4
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
148
628
2.42
21.60
3.0
3.0
nmol/l
0.9
0.8
0.87
122
470
(3016650) Hepatitis A virus Ab [Presence] in Serum
84
267
3.21
21.22
1.1
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2605
23680
1.59
20.46
45.2
13.8
mg/l
30.6
24.6
21.03
2516
18856
(3042111) Morphology [Interpretation] in Bone marrow Narrative
117
458
2.61
20.25
1.6
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1685
14099
1.42
20.19
4.8
3.0
u/l
70.4
53.2
5.67
1568
12780
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
332
1952
1.78
19.97
1.6
1.7
%
1.7
1.5
2.24
287
1670
(3006576) Bicarbonate [Moles/volume] in Blood
39
73
5.40
19.95
6.0
7.3
mmol/l
24.6
24.7
0.04
33
64
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
30
43
7.03
19.93
1.7
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
83
274
3.08
19.70
1.1
1.1
g/l
1.7
1.5
1.32
71
250
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
89
308
2.94
19.46
1.1
1.3
miu/ml
171.3
211.3
—
10
113
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
88
304
2.95
19.30
1.3
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
70
213
3.34
19.00
1.1
1.2
u/l
55.2
64.4
0.55
58
139
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
25
31
8.12
18.76
1.3
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
136
598
2.33
18.35
1.7
1.6
e6/l
15831.5
13961.7
0.12
101
429
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
20
19
10.59
18.22
1.1
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
496
3320
1.59
18.14
1.3
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
39
81
4.86
17.77
1.4
1.3
mmol/l
3.3
3.6
0.25
34
73
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
93
348
2.72
17.62
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
34
63
5.45
17.59
1.1
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
100
391
2.61
17.38
3.0
2.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
55
152
3.67
17.30
1.4
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
400
2573
1.64
17.19
2.9
2.3
ug/l
10.7
7.3
2.16
342
2198
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
42
97
4.38
16.85
1.1
1.1
ratio
1.1
1.1
0.08
14
33
(3018851) Theophylline [Moles/volume] in Serum or Plasma
16
12
13.40
16.80
2.1
1.5
umol/l
44.3
36.7
0.53
16
12
(3003327) Ova and parasites identified in Stool by Light microscopy
129
577
2.29
16.75
2.0
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
82
295
2.83
16.75
1.8
1.5
%
59.0
63.5
0.43
50
188
(3022217) INR in Platelet poor plasma by Coagulation assay
567
3981
1.52
16.62
30.8
28.5
inr
1.5
1.5
0.42
57
543
(3026389) Candida sp identified in Specimen by Organism specific culture
81
292
2.82
16.49
1.5
1.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
26
40
6.55
16.19
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
35
72
4.90
16.14
1.1
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
70
236
3.01
16.08
5.6
3.2
%
54.4
57.5
0.48
50
139
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
16
13
12.37
16.03
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
114
497
2.34
15.72
1.5
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
96
388
2.52
15.62
1.8
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
66
219
3.06
15.59
2.0
1.4
%
34.8
24.4
1.23
37
141
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1129
9097
1.38
15.46
5.9
4.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
142
686
2.12
15.27
1.4
1.5
ug/g
275.0
268.4
0.14
79
424
(3044889) 12 lead EKG panel
1982
17459
1.37
15.21
6.4
4.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
118
530
2.27
15.20
1.3
1.1
titre
150.8
76.4
0.85
13
28
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
67
229
2.97
15.04
2.7
2.8
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
34
74
4.63
14.69
1.1
1.1
u/ml
17.0
10.6
—
5
7
(3044640) Blood type and Crossmatch panel - Blood
1001
7972
1.38
14.51
3.6
2.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
17
18
9.49
14.33
1.6
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
17
18
9.49
14.33
1.6
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
17
18
9.49
14.33
1.6
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1373
11501
1.34
14.30
5.8
4.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
594
4335
1.46
14.15
1.3
1.2
u/ml
1.0
1.7
1.98
150
1096
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
80
311
2.61
14.13
1.7
1.7
ug/l
28.9
27.4
0.06
75
304
(40768795) Lymph node Pathology biopsy report
62
211
2.98
14.05
1.3
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
51
155
3.33
13.95
1.6
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
41
108
3.83
13.86
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
41
108
3.83
13.86
1.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
51
157
3.29
13.67
1.6
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
71
265
2.72
13.59
6.3
3.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
69
255
2.74
13.47
1.3
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
27
53
5.13
13.15
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
56
187
3.03
13.13
1.1
1.1
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
19
26
7.35
13.12
1.4
1.2
%
74.1
78.7
0.23
14
21
(3029075) Extractable nuclear Ab panel - Serum
29
61
4.79
13.06
1.1
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
24
43
5.62
12.88
5.2
2.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
38
100
3.83
12.88
7.9
7.3
mg/l
60.6
74.1
0.58
27
73
(3034891) Synovial lining cells/100 cells in Synovial fluid
40
110
3.67
12.74
1.9
1.4
%
2.9
3.1
0.05
13
28
(3032743) Legionella sp IgG Ab [Presence] in Serum
18
9
20.11
12.44
1.2
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
18
9
20.11
12.44
1.2
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
95
425
2.27
12.41
1.3
1.3
mmol/l
68.3
61.8
0.79
86
346
(3017732) Neutrophils [#/volume] in Blood
250
1548
1.67
12.38
3.6
3.0
e9/l
4.8
4.1
3.87
196
1088
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
74
297
2.53
12.29
1.6
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
74
298
2.52
12.21
1.6
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
74
298
2.52
12.21
1.6
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
74
299
2.51
12.12
1.6
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
766
5988
1.37
12.06
1.8
1.7
pmol/l
55161786.8
29558603.3
0.36
620
4821
(3024522) Salmonella sp identified in Specimen by Organism specific culture
74
300
2.50
12.04
1.6
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
349
2359
1.54
11.98
1.5
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
19
29
6.59
11.91
1.5
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
74
302
2.49
11.88
1.6
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
335
2250
1.55
11.83
2.5
2.1
ug/g
208.9
150.2
1.44
281
1752
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
29
67
4.36
11.68
1.4
1.3
%
25.0
21.9
0.18
19
55
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
35
94
3.75
11.55
1.5
1.5
%
53.1
72.2
1.63
24
71
(3013005) Retinol [Moles/volume] in Serum or Plasma
28
64
4.41
11.44
2.7
1.7
umol/l
1.9
2.0
0.36
28
59
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
30
73
4.14
11.32
1.1
2.1
%
230.5
172.9
1.23
25
68
(3001893) Eosinophils/100 leukocytes in Pleural fluid
32
83
3.88
11.10
1.5
1.5
%
1.8
1.9
0.07
24
64
(3019832) Treponema pallidum Ab [Presence] in Serum
146
799
1.87
11.09
1.5
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
42
132
3.21
10.95
1.6
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
42
132
3.21
10.95
1.6
1.5
—
—
—
0
0
(44806071)
14
17
8.27
10.61
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
71
301
2.39
10.54
1.1
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
38
115
3.33
10.53
2.6
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
853
6906
1.32
10.38
1.9
1.6
nmol/l
19.0
20.1
1.21
773
5785
(3017704) Immunofixation for Urine
45
153
2.97
10.30
1.4
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
17
27
6.33
10.27
1.6
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
11
10
11.04
10.16
1.5
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
55
210
2.65
10.16
1.2
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1149
9719
1.29
10.01
2.5
2.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
34
99
3.46
10.01
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
34
99
3.46
10.01
1.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
27
68
4.00
9.76
1.3
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
44
153
2.90
9.70
2.2
1.4
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
17
29
5.89
9.59
1.0
1.1
%
100.3
81.0
—
6
9
(3052592) Norovirus Ag [Presence] in Stool
21
44
4.80
9.53
2.0
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
34
104
3.29
9.30
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
231
3437
0.65
9.23
4.6
4.8
%
32.5
33.2
0.36
154
2192
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
48
180
2.69
9.22
1.3
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
39
131
3.00
9.15
1.5
1.6
u/l
8.6
6.1
0.40
23
58
(3041918) Cholesterol [Moles/volume] in Pleural fluid
21
46
4.59
9.05
1.3
1.2
mmol/l
1.8
1.5
0.66
12
28
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
17
31
5.51
8.97
1.4
1.2
u/l
417.4
1075.0
0.26
11
21
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
758
6148
1.31
8.89
3.3
2.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
22
51
4.34
8.86
1.0
1.4
%
98.1
84.4
0.75
11
29
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
78
3.61
8.82
4.0
2.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
78
3.61
8.82
4.0
2.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
27
74
3.67
8.71
1.2
1.3
ug/l
136.4
909.2
0.88
13
38
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
46
174
2.67
8.70
1.4
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
27
75
3.62
8.55
3.2
2.3
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
14
22
6.39
8.52
1.4
1.2
ug/l
134.0
139.6
—
7
14
(3044927) Protein electrophoresis panel - Urine
69
318
2.20
8.50
1.2
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
16
29
5.54
8.49
1.0
1.1
%
83.8
80.0
—
5
8
(42529406) Shigella sp [Presence] in Stool by Culture
114
633
1.83
8.35
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
45
173
2.62
8.26
1.3
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
113
629
1.83
8.22
1.3
1.1
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
16
30
5.36
8.20
1.3
1.4
%
25.9
14.8
—
9
17
(3009542) Hematocrit [Volume Fraction] of Blood
2215
20532
1.27
8.16
41.8
16.1
%
37.9
38.8
3.80
1397
12876
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
396
2949
1.39
8.14
3.0
3.9
ug/l
12.3
25.5
1.17
324
2445
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
10
11
9.12
8.08
2.4
1.9
%
4.1
1.5
—
10
11
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
12
17
7.08
7.99
1.9
1.6
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
21
51
4.14
7.99
1.0
1.1
%
95.3
84.4
—
10
28
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
41
154
2.68
7.89
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
44
173
2.57
7.75
1.3
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
22
57
3.88
7.69
1.0
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
25
71
3.54
7.69
3.4
1.6
umol/l
149.1
89.5
0.56
15
43
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
19
44
4.34
7.68
1.4
1.5
%
4.3
4.2
—
10
18
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
110
623
1.79
7.59
1.3
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1310
11527
1.23
7.47
2.3
2.1
pmol/l
90.8
93.7
1.40
707
5958
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
24
68
3.55
7.41
5.8
7.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
255
3556
0.69
7.26
11.9
7.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
100
558
1.82
7.26
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
174
1130
1.57
7.17
1.2
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
16
6.90
7.15
4.7
7.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
221
1515
1.49
7.10
2.4
2.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
14
27
5.20
6.97
2.1
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
35
4.59
6.93
1.3
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
278
2004
1.42
6.88
4.1
2.7
ml/min/173m2
54.2
60.9
2.35
133
851
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1911
17576
1.22
6.81
3.9
3.8
pmol/l
15.0
15.0
0.46
1715
15545
(3017817) Protein [Mass] in Urine collected for unspecified duration
48
210
2.31
6.76
1.5
2.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
6
16.72
6.74
1.3
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
27
89
3.05
6.61
1.4
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
34
129
2.65
6.47
1.9
1.6
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
14
29
4.84
6.45
1.0
1.3
nmol/l
10.9
5.1
—
9
23
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
19
51
3.74
6.36
1.2
1.3
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
12
22
5.47
6.28
1.2
1.3
u/l
19.0
24.1
—
6
15
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
20
57
3.52
6.15
1.4
1.2
ug/l
9.3
9.8
0.21
20
57
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
16
39
4.12
6.08
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
219
1547
1.45
6.07
1.2
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
29
106
2.75
5.95
1.8
2.5
ml
1952.5
2018.6
0.12
22
93
(3016750) Collection duration of Urine
38
160
2.39
5.87
1.6
1.9
min
456.6
495.3
0.89
23
121
(21494890) Protein electrophoresis panel - 24 hour Urine
56
277
2.04
5.87
1.5
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
973
8495
1.21
5.57
3.6
3.1
mmol/l
6.9
7.3
2.51
797
7003
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
11
21
5.25
5.52
1.0
1.3
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
15
38
3.96
5.44
1.4
1.2
mmol/l
0.5
3.4
—
9
27
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
5
16.04
5.41
1.4
1.6
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
8
5
16.04
5.41
1.1
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
8
5
16.04
5.41
1.1
1.0
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
29
112
2.60
5.38
1.1
1.1
u/l
88.0
91.4
0.08
22
85
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
70
1216
0.57
5.35
1.9
1.8
—
—
—
0
0
(3036603) Volume of Urine
35
149
2.36
5.31
1.4
1.4
ml
1531.3
1763.7
0.54
11
43
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
29
113
2.58
5.29
1.1
1.1
u/l
28.2
33.7
0.20
21
82
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
22
5.01
5.26
14.0
8.8
mmol/l
5.8
5.8
0.03
11
22
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
11
22
5.01
5.26
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
49
241
2.05
5.25
1.3
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
25
91
2.76
5.20
1.3
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
37
165
2.26
5.07
3.2
2.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
949
8342
1.20
4.94
3.7
3.2
mg/l
743.5
270.9
1.76
659
5280
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
819
9365
0.83
4.90
4.0
4.8
%
21.4
22.2
0.72
365
5054
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
40
188
2.14
4.84
1.8
1.9
u/l
148.0
1065.9
1.04
12
63
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
28
4.30
4.82
1.1
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
78
460
1.71
4.81
1.3
1.2
u/l
41.0
26.7
0.73
67
398
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2288
23967
0.83
4.80
5.1
5.4
mmol/l
2.5
2.6
10.04
2030
21591
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
19
62
3.08
4.79
1.7
1.5
ug/l
0.3
0.4
0.51
14
33
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2224
23345
0.84
4.71
4.7
4.7
mmol/l
4.4
4.5
4.30
1961
21126
(3037121) Protein [Mass/volume] in Urine
136
926
1.49
4.62
3.3
2.9
g/l
0.4
0.3
0.87
78
370
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
35
159
2.21
4.62
1.3
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
58
1014
0.56
4.58
1.3
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
18
59
3.06
4.51
5.2
8.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
159
1124
1.44
4.47
2.7
3.2
pmol/l
4.2
4.4
2.66
133
968
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
40
774
0.51
4.45
1.7
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
33
149
2.23
4.43
1.7
1.8
u/field
0.8
2.0
2.11
25
104
(40761511) CBC panel - Blood by Automated count
2532
24316
1.21
4.37
33.9
14.3
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
7
6
11.69
4.27
1.7
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2206
23111
0.85
4.25
4.6
4.7
mmol/l
1.4
1.4
1.75
1944
20771
(3020682) Albumin/Creatinine [Ratio] in Urine
988
8812
1.18
4.22
4.5
3.9
mg/mmol
15.1
8.1
3.11
658
5558
(3047189) Immunofixation for 24 hour Urine
30
133
2.27
4.22
1.7
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
571
6669
0.82
4.17
2.7
3.3
ug/l
0.7
0.8
1.35
406
4783
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
15
47
3.20
4.05
1.2
1.1
mg/l
0.9
0.8
—
10
36
(3020191) Ethanol [Moles/volume] in Serum or Plasma
31
142
2.19
4.05
1.5
1.3
promille
1.3
1.0
0.53
25
106
(40763480) Human metapneumovirus Ag [Presence] in Specimen
7
7
10.02
4.01
1.7
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
7
10.02
4.01
1.9
5.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
9
14
6.44
3.98
1.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
11
28
3.94
3.97
2.1
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
28
124
2.27
3.96
1.6
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
28
124
2.27
3.96
1.6
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
66
399
1.67
3.79
1.3
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
38
194
1.97
3.77
8.9
2.7
%
10.0
10.8
0.59
38
194
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
39
202
1.94
3.72
1.2
1.1
u/ml
2.4
1.3
0.26
21
75
(1761868) Lipid panel - Serum or Plasma
612
7035
0.84
3.71
3.3
3.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
15
51
2.95
3.57
2.1
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
42
228
1.85
3.50
1.4
1.4
mosm/kgh2o
266.7
277.3
2.74
35
168
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
8
13
6.17
3.50
1.5
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
72
456
1.59
3.47
1.1
1.2
mmol/l
3.8
3.9
0.18
64
419
(3019550) Sodium [Moles/volume] in Serum or Plasma
2597
25130
1.19
3.46
45.2
17.4
mmol/l
138.9
139.7
41.50
2557
24434
(3004716) Salmonella sp identified in Stool by Organism specific culture
120
849
1.43
3.43
1.4
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
43
237
1.83
3.43
1.8
2.1
ml
558.8
632.1
0.53
27
150
(3010144) Erythrocytes [#/volume] in Synovial fluid
44
246
1.80
3.36
1.6
1.3
e6/l
171319.5
114911.3
0.20
29
172
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
95
2.33
3.33
1.4
1.8
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
40
218
1.85
3.31
2.0
1.9
g/24h
0.6
0.8
—
5
8
(3023103) Potassium [Moles/volume] in Serum or Plasma
2599
25177
1.19
3.28
45.5
17.6
mmol/l
4.0
4.0
1.31
2556
24447
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2259
21645
1.16
3.28
5.0
4.6
mu/l
2.1
2.0
0.54
2053
19295
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
7
8.58
3.26
1.3
2.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
17
66
2.58
3.21
1.6
2.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
580
0.53
3.19
1.9
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
34
178
1.92
3.19
1.1
1.1
u/ml
6.6
4.3
0.30
21
74
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
111
2.17
3.12
1.7
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
26
125
2.09
3.08
2.0
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
16
5.01
3.05
1.0
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
75
496
1.52
3.04
1.2
1.1
u/ml
13.5
9.9
—
5
38
(3014271) Vancomycin [Susceptibility]
31
160
1.95
3.04
2.9
2.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
13
45
2.90
3.02
1.5
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
29
147
1.98
2.99
1.2
1.0
u/ml
0.5
1.5
0.83
13
34
(3039443) Prostate specific Ag panel - Serum or Plasma
19
409
0.46
2.99
1.3
1.7
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
5
5
10.01
2.98
1.2
3.4
mmol/l
15.5
28.2
—
5
5
(3040893) Potassium [Moles/volume] in Capillary blood
5
5
10.01
2.98
3.2
3.2
mmol/l
4.3
4.2
—
5
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2145
22329
0.88
2.98
4.2
4.2
mmol/l
1.4
1.3
7.66
1887
19856
(3013512) EKG study
897
8138
1.14
2.86
5.7
4.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
172
1.87
2.81
1.2
1.1
u/ml
0.4
2.1
0.87
17
65
(40768441) Liver Pathology biopsy report
29
152
1.92
2.75
1.6
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
57
364
1.58
2.73
1.4
1.4
u/l
9.4
9.8
0.12
42
291
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
14
5.01
2.72
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
60
388
1.56
2.72
4.5
2.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
24
118
2.04
2.71
1.1
1.1
u/ml
0.7
3.2
1.18
17
45
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
16
66
2.43
2.70
1.1
1.1
miu/ml
1536.4
1734.9
0.24
16
66
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
6
10
6.01
2.70
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
319
2679
1.21
2.65
1.3
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
21
99
2.13
2.64
1.1
1.2
%
53.6
63.1
—
5
9
(3014133) Dog dander IgE Ab [Units/volume] in Serum
24
120
2.01
2.60
1.0
1.0
u/ml
0.8
2.8
1.10
15
48
(3018133) Calcium [Moles/volume] in Urine
9
25
3.61
2.57
2.2
2.1
mmol/l
1.6
3.2
—
9
20
(3020393) Adenovirus Ag [Presence] in Stool
8
20
4.01
2.56
1.4
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
16
68
2.36
2.55
1.3
1.1
—
—
—
0
0
(4198724)
10
33
3.04
2.52
1.2
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
16
4.38
2.47
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
62
414
1.51
2.46
1.9
1.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
25
131
1.92
2.40
1.3
1.3
nmol/l
1.3
1.1
0.51
19
98
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
335
0.47
2.39
1.4
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
52
2.51
2.35
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
105
2.01
2.30
1.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
74
520
1.43
2.30
1.2
1.3
mg/l
896.4
545.8
0.44
66
487
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
24
3.34
2.18
1.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
14
4.29
2.15
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
116
1.90
2.10
1.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
43
2.56
2.09
5.4
8.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
31
2.91
2.07
1.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
15
4.00
2.04
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
58
0.00
2.03
0.0
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
42
270
1.56
2.03
1.2
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
52
351
1.49
2.02
1.4
1.4
iu/l
33.0
31.0
0.14
40
297
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
38
2.64
2.01
1.1
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
63
443
1.43
1.99
1.2
1.5
e6/l
111.8
816.2
2.07
50
365
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
7
21
3.34
1.96
1.0
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
91
1.98
1.95
1.1
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
51
2.36
1.95
1.1
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
11
4.55
1.94
1.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
100
764
1.32
1.92
1.7
1.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
17
85
2.01
1.90
1.2
1.2
g/l
29.4
39.8
—
7
41
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1087
11581
0.91
1.90
4.6
5.6
ug/l
5.0
4.6
0.10
934
10294
(3005011) Chlamydia sp Ab [Titer] in Serum
7
22
3.19
1.88
1.3
1.7
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
28
2.86
1.86
1.0
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
20
107
1.87
1.86
1.1
1.0
u/ml
0.4
0.3
0.04
11
31
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
62
442
1.41
1.84
1.1
1.4
e6/l
24.9
24.0
0.02
45
344
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
43
285
1.52
1.84
1.7
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
39
253
1.55
1.84
1.8
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
198
0.45
1.83
2.8
1.5
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
12
4.17
1.82
4.0
7.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
57
796
0.71
1.81
1.1
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2292
23541
0.90
1.80
5.2
5.1
mmol/l
6.1
6.1
0.12
2059
20924
(3016244) Insulin [Units/volume] in Serum or Plasma
15
73
2.06
1.80
2.9
2.8
mu/l
11.9
20.7
1.72
15
66
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
40
264
1.52
1.76
1.8
2.0
u/field
1.1
1.7
0.71
21
88
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
18
3.34
1.74
1.0
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
24
2.92
1.72
1.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2576
25216
1.12
1.69
22.8
10.4
u/l
24.3
25.4
2.40
2537
24036
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
42
2.39
1.67
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
122
1513
0.80
1.67
5.6
3.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
659
6049
1.11
1.67
1.5
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
121
1501
0.80
1.66
1.1
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
25
2.80
1.65
1.0
1.3
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
13
63
2.07
1.59
1.1
1.2
%
26.4
22.4
—
5
5
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
57
2.11
1.55
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
85
1.89
1.54
1.0
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
214
1835
1.18
1.51
2.8
2.1
nmol/l
11.9
12.2
0.27
183
1576
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
86
1.86
1.50
1.4
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
58
2.07
1.49
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
32
210
1.53
1.48
1.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
109
1.75
1.46
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
16
87
1.84
1.45
2.2
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
38
2.37
1.45
3.3
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
28
2.50
1.45
1.4
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
34
229
1.49
1.41
1.6
1.6
u/ml
15.3
20.7
—
7
53
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
120
984
1.23
1.38
1.5
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
121
0.41
1.37
1.2
1.9
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
23
2.61
1.36
1.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
23
2.61
1.36
1.0
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
51
374
1.37
1.36
3.2
2.0
mg/l
24.7
26.3
0.07
15
84
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
17
2.94
1.36
1.0
2.8
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
17
2.94
1.36
1.2
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
15
82
1.83
1.35
1.2
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
19
112
1.70
1.35
2.3
1.7
—
—
—
0
0
(44813793)
19
115
1.66
1.24
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
579
5363
1.10
1.24
5.7
4.2
kg/l
1.0
1.0
0.52
103
832
(3032773) Endomysium IgG Ab [Titer] in Serum
25
164
1.53
1.20
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
64
1.88
1.18
1.0
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
123
1031
1.20
1.17
2.9
3.1
u/ml
259.0
5033.8
1.06
100
877
(4094501)
52
676
0.77
1.13
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
191
2180
0.87
1.12
1.4
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
21
2.38
1.09
1.2
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
45
338
1.34
1.08
1.3
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
13
74
1.76
1.06
1.8
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
47
613
0.76
1.06
3.6
2.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
19
121
1.57
1.05
1.0
1.8
umol/l
5.4
15.0
1.01
14
76
(3050129) First trimester maternal screen panel - Serum or Plasma
6
121
0.49
1.05
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
65
517
1.26
1.04
1.6
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
16
99
1.62
1.00
1.0
1.2
nmol/l
143.4
129.3
0.36
16
99
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
48
617
0.77
0.99
2.1
1.7
mg/l
33.3
3.3
4.29
43
452
(3000034) Microalbumin [Mass/volume] in Urine
33
240
1.38
0.98
1.8
3.2
mg/l
28.2
22.7
0.17
26
191
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
61
1.81
0.98
1.0
1.1
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
5
23
2.18
0.98
1.8
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
36
266
1.36
0.98
3.4
3.8
umol/l
294.5
336.5
0.93
30
226
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
84
1.67
0.97
3.4
2.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
84
1.67
0.97
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
55
1.82
0.92
1.9
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
28
2.14
0.91
1.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
29
2.07
0.89
1.0
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
44
1.82
0.85
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
31
1.94
0.84
1.8
2.4
u/field
0.5
0.4
—
6
31
(4027681)
15
96
1.57
0.84
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
153
1350
1.14
0.84
2.8
2.9
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
18
122
1.48
0.80
3.2
6.7
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
48
1.67
0.78
1.7
2.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
66
1.67
0.78
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
361
3353
1.09
0.78
1.4
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
27
0.00
0.77
0.0
1.5
—
7.9
—
0
15
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
292
0.72
0.77
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
44
349
1.26
0.77
1.1
1.1
iu/ml
89.5
71.1
0.09
13
63
(40768793) Breast Pathology biopsy report
55
449
1.23
0.76
1.5
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
69
579
1.20
0.73
2.6
3.1
u/ml
37.6
870.6
1.18
64
532
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
39
1.80
0.72
3.3
1.9
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
68
1.62
0.71
2.1
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
18
126
1.43
0.70
2.0
1.8
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
27
1.85
0.68
1.0
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
42
1.67
0.68
1.9
2.7
—
—
—
0
0
(4146454)
26
340
0.76
0.67
2.5
2.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
92
0.54
0.67
1.2
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
126
1121
1.13
0.65
1.1
1.2
iu/ml
105.1
131.5
0.31
38
403
(3023410) Appearance of Cerebral spinal fluid
25
189
1.33
0.64
1.3
1.6
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
29
1.73
0.64
2.8
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2271
22388
1.05
0.63
36.3
14.2
ml/min/173m2
72.0
73.5
2.25
2040
18492
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
105
0.57
0.61
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
105
0.57
0.61
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
105
0.57
0.61
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
105
0.57
0.61
1.5
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
30
1.67
0.61
1.0
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
82
713
1.15
0.60
2.4
2.2
ug/min
127.1
81.7
0.51
51
417
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.1
—
25.8
—
0
17
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
140
1.36
0.58
2.3
2.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
354
0.79
0.58
1.9
1.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
98
1.43
0.56
1.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
88
0.57
0.56
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
88
0.57
0.56
1.2
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1925
18934
1.04
0.55
50.9
19.6
g/l
328.2
332.1
59.89
1906
18737
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
37
1.62
0.55
1.7
1.3
—
—
—
0
0
(1002224) Polysomnography panel
52
612
0.85
0.55
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
100
890
1.13
0.54
1.6
1.8
—
—
—
0
0
(4281824)
17
227
0.75
0.53
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
62
1.45
0.53
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
33
270
1.22
0.49
1.7
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
109
0.64
0.48
1.4
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
31
377
0.82
0.48
1.9
1.5
pmol/l
242.6
253.2
0.04
31
371
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
14
189
0.74
0.48
1.0
1.0
ng/l
31.5
46.0
—
6
120
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
14
188
0.74
0.46
1.0
1.0
ng/l
281.2
328.2
—
6
120
(3000285) Sodium [Moles/volume] in Blood
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
31
256
1.21
0.44
1.7
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
31
1.61
0.43
1.8
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
29
239
1.22
0.42
2.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
246
2319
1.07
0.42
5.1
3.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
122
1.31
0.42
1.1
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
32
1.56
0.42
2.0
2.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
54
472
1.15
0.41
1.5
1.8
iu/l
4.8
4.2
0.11
15
147
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
33
1.52
0.41
2.0
2.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
59
1.36
0.41
1.8
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
31
259
1.20
0.40
1.9
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
31
259
1.20
0.40
1.9
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
35
296
1.18
0.40
1.7
1.3
nmol/l
28.3
0.7
0.49
29
285
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
35
296
1.18
0.40
1.7
1.3
nmol/l
0.1
0.4
—
6
21
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2285
22622
1.04
0.40
6.9
6.5
mmol/mol
42.1
40.6
6.93
2112
20517
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
76
842
0.90
0.38
6.1
4.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2616
25976
1.04
0.38
56.1
21.8
e9/l
249.2
237.8
12.33
2565
25148
(3024731) MCV [Entitic volume]
2616
25981
1.04
0.36
55.8
21.7
fl
92.4
91.7
10.79
2581
25464
(3035941) MCH [Entitic mass]
2616
25981
1.04
0.36
55.7
21.7
pg
30.3
30.5
3.00
2583
25466
(3026361) Erythrocytes [#/volume] in Blood
2616
25982
1.04
0.36
56.0
21.8
e12/l
4.3
4.4
44.04
2555
25060
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
198
1.21
0.36
2.1
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2616
25985
1.04
0.35
56.1
21.8
e9/l
8.3
6.8
70.17
2557
25056
(3011288) Drugs identified in Urine by Screen method
20
162
1.24
0.35
2.6
1.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2616
25986
1.04
0.35
56.5
21.9
g/l
128.1
134.4
80.24
2583
25486
(3051593) INR in Capillary blood by Coagulation assay
21
173
1.22
0.32
7.4
16.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
39
445
0.87
0.32
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
30
258
1.16
0.31
2.0
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
30
258
1.16
0.31
1.7
1.3
nmol/l
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
99
0.71
0.30
1.0
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
21
250
0.84
0.30
1.2
1.2
mmol/l
7.5
7.7
0.08
15
176
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
155
1463
1.06
0.29
2.3
2.4
au/ml
61.2
22.2
—
5
41
(3022621) pH of Urine by Test strip
184
1748
1.06
0.28
4.9
3.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
138
1301
1.06
0.27
1.4
1.3
au/ml
21.6
57.6
—
5
50
(3011985) Renin [Units/volume] in Plasma
26
301
0.86
0.27
1.3
1.3
mu/l
35.7
70.3
1.26
21
261
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
118
0.76
0.27
1.2
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
9
119
0.76
0.27
1.4
1.3
mmol/l
6.3
6.2
—
9
112
(3033799) Differential panel - Peritoneal fluid
9
72
1.25
0.25
2.3
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
96
1.25
0.24
1.3
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
91
972
0.93
0.24
1.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
10
0.00
0.21
0.0
1.1
—
7.7
—
0
10
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
98
1.23
0.21
1.0
1.0
u/l
0.9
1.2
—
7
49
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
89
1.24
0.21
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
272
0.88
0.20
1.5
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
84
790
1.07
0.20
1.6
1.7
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
174
1.15
0.19
1.1
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
29
260
1.12
0.19
2.8
2.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
58
1.21
0.18
1.3
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
64
600
1.07
0.17
8.0
3.3
mg/l
31.5
26.5
0.59
53
378
(4024509)
30
273
1.10
0.16
1.5
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
638
6468
0.98
0.14
1.7
1.6
mmol/l
1.5
1.3
5.23
529
5367
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
84
1.19
0.14
1.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
50
474
1.06
0.11
2.6
1.4
nmol/l
1.0
0.8
1.18
39
391
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
26
280
0.93
0.10
1.3
1.3
pmol/l
214.6
279.9
0.76
21
212
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
44
1.14
0.10
1.4
1.2
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
10
87
1.15
0.09
2.2
2.1
e6/l
163.4
769.8
—
5
72
(3006270) Folate [Moles/volume] in Blood
23
248
0.93
0.09
1.1
1.2
nmol/l
287.6
331.7
0.49
18
190
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
19
174
1.09
0.09
3.4
5.1
u/ml
137.8
38.0
—
6
53
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
54
1.11
0.09
1.5
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
75
1.07
0.07
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
99
1.11
0.06
1.7
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
112
1143
0.98
0.06
2.6
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
228
2253
1.01
0.05
1.7
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
140
0.93
0.04
4.1
4.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
17
160
1.06
0.04
1.1
1.3
mmol/l
10.7
12.0
—
8
48
(3019420) Tryptase [Mass/volume] in Serum or Plasma
11
101
1.09
0.04
1.4
1.6
ug/l
8.4
10.3
0.28
11
86
(4034850)
80
812
0.98
0.02
14.6
10.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
49
496
0.99
0.00
1.0
1.1
—
—
—
0
0
(44806420)
10
105
0.95
0.00
1.8
2.6
—
—
—
0
0
(4211845)
15
155
0.97
0.00
3.7
3.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
16
156
1.03
0.00
1.2
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
118
1.02
0.00
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
286
2856
1.00
0.00
6.1
4.1
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
62
0.97
0.00
2.2
1.5
ug/l
8.6
3.6
—
6
42
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
49
1.02
0.00
2.2
2.1
nmol/l
136.6
138.1
—
5
42
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
6.8
—
67.0
—
0
6
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
1831.7
—
0
6
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
63
0.95
0.00
1.0
2.1
ug/l
1.0
1.3
—
6
57
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
211.3
—
0
8
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
385.3
—
0
6
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ILD_HOSPITAL_PNEUMONIA_SEPSIS – ILD, hospital admissions 3, with pneumonia sepsis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).